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ABSTRACT OF THE DISSERTATION 
 
 
 
Part I Development of Nucleophilic Acylation Catalysts 
Part II Chiral Brønsted Acid Catalyzed Enantioselective Alcoholysis 
 
by 
Guojian Lu 
Doctor of Philosophy in Chemistry 
Washington University in St. Louis, 2011 
Professor Vladimir B. Birman, Chairperson 
 
 
     Chiral bicyclic amidines and isothioureas developed in our group have been showed 
as a new type of nucleophilic acyl transfer catalysts. Based on the previous achievement 
in our group, several aza-analogues and a 5,7-menbered ring bicyclic analogue of THTP 
were prepared. Its synthesis proved to be more laborious than that of the THTP analogue 
derivative, and the enantioselectivity was substantially lower. 
      Based on the previous discovery in our group that 1,2,4-triazole anion, as an active 
acyl transfer catalyst, can promote aminolysis and transesterification of moderately 
activated or even unactivated esters, a systematic study of pyrazole derivatives in this 
iii 
transformation was demonstrated. Two types of derivatives with equal or better activity 
than pyrazole itself were identified. 
     Based on our achievement in the Dynamic Kinetic Resolution (DKR) of azlactones 
via acyl transfer catalysis, a new method of DKR of azlactones catalyzed by chiral 
BrØnsted acid was developed, high enantioselectivity (85-92% ee) were obtained for the 
aryl-substituted azlactones. It was the first time that chiral BrØnsted acid catalysis was 
applied to the enantioselective acylation reaction. The application of this new method 
was also applied to the kinetic resolution of oxazinones, modest enantioselectivity was 
obtained (s≤9). 
 
iv 
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Chapter 1 Synthesis and exploration of THTP analogues for acylation 
of alcohol 
1.1 Nucleophilic acyl transfer catalysis 
      Acylation is a fundamental organic reaction which an acyl group is added to alcohols, 
amines, or other nucleophiles. Catalytic enantioselective acylation has attracted a great 
deal of interest from organic chemists in recent years
1
. Kinetic resolution
2
 of secondary 
alcohols is one of the most important transformations in this category. (Figure 1.1) 
Figure 1.1 KR of alcohols 
 
       Its practical significance lies in the fact that many enantiopure alcohols are important 
pharmaceutical drugs or intermediates. Most of the enantioselective acylation catalysts 
described to date
3
 belong to the class of nucleophilic, or Lewis base catalysts
4
. Some of 
the best catalysts developed by other groups are shown in Figure 1.2.
5
 They are believed 
to operate via the acyl transfer mechanism outlined in general form in Figure 1.3. Most of 
the catalysts illustrated above and many of their analogues incorporate in their structures 
several well-known achiral acyl transfer catalysts, such as the DMAP (1.6)
6
, PPY (1.7)
7
, 
N-methylimidazole (NMI) (1.8)
8
, tributylphosphine (1.9)
9
 and N-Heterocyclic carbene 
(NHC) (1.10).
10
 (Figure 1.4) 
2 
Figure 1.2 Chiral nucleophilic catalysts developed by other groups  
 
Figure 1.3 Acyl transfer catalysis 
 
Figure 1.4 Achiral nucleophilic catalysts in acyl transfer reaction  
 
      Chiral DMAP- and imidazole-based catalyst designs are the most popular because of 
their significant catalytic activities. However, due to the planar structures of DMAP and 
imidazole, the introduction of chiral environment to those core structures is a challenging 
problem.  
3 
1.2 The amidine-based catalysts developed in the Birman group 
      In 2003, our group developed a conceptually new approach to designing 
enantioselective acyl transfer catalysts
11
. Instead of inventing new ways to incorporate 
chirality into the structures of known acylation catalysts, Birman and coworkers decided 
to look for a new type of achiral catalyst, which would be easy to make chiral. A known 
heterocyclic compound, DHIP looked especially promising (Figure 1.5).  
Figure 1.5 Structure of DHIP                          
 
       In contrast to DMAP or imidazole, the carbon atom next to the nucleophilic nitrogen 
(N1) is tetrahedral, and therefore easily transformed into a chiral center. The electronic 
properties of this system can be tuned by introducing an electron-withdrawing or -
donating group X on the pyridine ring at C6.  
Figure 1.6 Several generations of amidine-based catalyst developed in our group 
 
     After demonstrating that the parent compound is catalytically active, our group went 
on to develop several generations of chiral catalysts illustrated in Figure 1.6. As can be 
seen from their structures, both the aromatic part and the imidazoline ring have 
4 
undergone modifications. The only part of the catalyst design that has remained constant 
is the amidine moiety itself, which is why these catalysts are now known as Amidine-
based catalysts, or ABCs. 
     ABCs have been successfully applied to many enantioselective reactions both by our 
group and others. These include:  KR of secondary alcohols
12a, b, c, d
 and desymmetrization 
of diols via O-acylation;
12e
 KR of lactams via N-acylation;
12f, g
 conventional and Dynamic 
KR of several types of acyl donors via alcoholysis,
12h, i, j
 Steglich rearrangement (C-
acylation);
12k, l
 [2+2] and [2+4] cycloadditions of ketenes,
12m, n, o
 and epoxide opening.
12p
  
1.3 Objectives of this study 
      During the studies outlined above, it became apparent that each structural subtype of 
ABCs displays its own unique character and reaction scope. Therefore, it was of great 
interest to explore new variations of the core structure. With this in mind, we decided to 
focus on modifying THTP, an active achiral catalyst, which ultimately served as the core 
of such catalysts as HBTM and HBTM-2. (Figure 1.7) Two types modifications have 
been undertaken, as discussed below. 
Figure 1.7 Structure of HBTM and HBTM-2     
 
      Aza-analogues of THTP.  Specifically, we wanted to explore the effects of replacing 
one of the carbon atoms in the 6-membered ring with a tertiary amine. Our motivation 
was twofold: first, we sought to examine the effect of this substitution on the catalytic 
5 
activity (due to the so-called alpha-effect)
13
(Figure 1.8) and second, develop a synthetic 
route to chiral analogues of aza-THTP starting with commercially available chiral 1,2-
aminoalcohols. (Scheme 1.1) 
Figure 1.8 Design of aza-analogues derivatives 
 
Scheme 1.1 Synthetic route to the chiral analogues of aza-THTP  
 
        Ring-expanded analogues of THTP. Earlier studies in our group had established 
that the catalytic activities of both bicyclic amidines and isothioureas are critically 
dependent on the sizes of both rings. Thus, DBN and its sulfur analogue THTP are highly 
active, while similar compounds with a 6- or 7-membered ring A or 5-membered ring B 
are virtually inactive.
14
 (Figure 1.9) 
 
 
 
 
6 
Figure 1.9 Structure of bicyclic amidines and isothioureas 
 
Figure 1.10 The 5, 7-membered ring bicyclic analogue 
 
      One potentially interesting variation that had remained unexplored was to expand ring 
B to 7-membered. (Figure 1.10) If successful, such a structure could give rise to a new 
generation of chiral catalysts that might interact with substrates in a fashion different 
from the existing ABCs.  
1.4 Preparation of achiral aza-analogues of THTP 
      Fortunately for us, the synthesis of several achiral aza-analogues of THTP had been 
described in the literature
15 
long before anyone was interested in their catalytic activities. 
We employed their synthesis with some slight modification to the experimental 
procedure. Aza-THTP (1.19) was prepared as follows. Treatment of 2-bromoethylamine 
hydrobromide with methylhydrazine gave compound 1.31 via selective alkylation of the 
substituted nitrogen
15b
. Without further purification, the resulting crude aminohydrazine 
(1.31) was heated with CS2 directly to provide 1-methyl-1,2,4-triazinane-3-thione (1.32) 
in 43% overall yield. Its cycloalkylation with 1,2-dibromoethane proceeded 
7 
regioselectively at the hydrazine nitrogen, consistent with the literature report. (Scheme 
1.2) 
Scheme 1.2 Synthesis of compound 1.19 
 
      The regioisomer of 1.19 was prepared via a different synthetic route. (Scheme 1.3) 2-
(aziridin-1-yl)ethanol (1.33) underwent nucleophilic ring opening with methylhydrazine 
to give compound 1.34.  Treatment with CS2 gave compound 1.35, which was cyclized 
with SOCl2 to give the desired compound 1.20. The structure of 1.20 follows 
unambiguously from the synthetic route. Its comparison with 1.19 also confirmed the 
identity of the latter. 
Scheme 1.3 Synthesis of compound 1.20 
 
      In contrast to the cycloalkylation used to prepare 1.19, treatment of 1.32 with 
chloroacetone and 2-bromoacetophenone produced the opposite regioselectivity, again in 
accord with the original study. The difference is explained in terms of kinetic vs. 
thermodynamic control in the final cyclization step. Thus, compounds 1.36 and 
compound 1.37. These analogs are structurally analogous to 1.20. (Scheme 1.4) 
 
8 
Scheme 1.4 Synthesis of compound 1.36 and compound 1.37 
 
1.5 Catalytic activities of THTP analogues for acylation of methanol 
      Having prepared several aza-analogues of THTP, we evaluated their catalytic 
activities using the standard acylation of methanol test. The results are shown in Table 
1.1. Compound 1.19 displayed the same activity as THTP (entries 2 and 3). In sharp 
contrast, its isomer 1.20 is virtually inactive. Modest catalytic activity was detected in the 
case of compounds 1.36 and 1.37, presumably due to the aromaticity of the thiazole ring, 
which enhances the nucleophilicity of the amidine nitrogen.  Overall, the results of this 
preliminary study were encouraging enough to proceed with the synthesis of a chiral 
analogue of 1.19. 
 
 
 
 
 
 
 
 
 
9 
Table 1.1 Catalytic activities of THTP analogues for acylation of methanol 
 
entry Catalyst 
Catalyst 
loading 
(mol %) 
t1/2 
1 none 0 18 h
a 
2 THTP 0.1 25 min
a 
3 
1.19 
0.1 25min 
4 
1.20 
5 10h 
5 
1.36 
0.1 
5 
15h 
2.5h 
6 
1.37 
0.1 
5 
13h 
45min 
                    
a
Data from previous study
14
 
1.6 Preparation of the chiral version of aza-analogues catalyst 
      Previous studies in our group on designing chiral ABCs indicated that the most 
suitable substituent for the C2 position is the phenyl group. Accordingly, we decided to 
prepare the 2-phenyl analogue of 1.19 starting with (R)-phenylglycinol using the 
10 
synthetic route shown in Scheme 1.5. Following a literature precedent, the amino alcohol 
was treated with 2 equivalents of p-NO2C6H4SO2Cl (NsCl) and base to effect both 
protection of the amino group and cyclization to the activated N-sulfonylaziridine (1.39). 
Upon treating 1.39 with methylhydrazine, an inseparable mixture was obtained, 
containing predominantly the products arising from the attack of the methylated nitrogen 
at either side of the aziridine ring
16
. 
Scheme 1.5 Synthesis of chiral aza-analogues of THTP 
 
      After removing the nosyl group with PhSH, the crude mixture was treated with CS2 to 
give 3 compounds: the desired (1.42b), its isomer (1.42c), and imidazolidine-thione 
(1.42a). The mixture of 1.42b and 1.42c was heated with 1,2-dibromoethane to afford 
1.43b and 1.43c in about 1:1 ratio, which were separated by column chromatography. 
11 
(Scheme 1.5) The identity of each of these isomers was confirmed by 
1
HNMR, 
13
CNMR, 
HMQC and NOE. (See appendix)  
1.7 Enantioelectivity for the Kinetic resolution of secondary alcohol 
      Compound 1.43b and 1.43c were tested for the kinetic resolution of 1-phenylpropanol. 
To our surprise, compound 1.43b displayed no catalytic activity (0% conversion after 7h, 
at 1 mol% catalyst loading). The catalytic activity of its isomer 1.43c was much better 
(similar to that of HTM and HBTM), which is consistent with lack of substitution at C2. 
Although the selectivity factor was low, even this result is remarkable, considering that 
the chiral center is on the β position relative to the nucleophilic nitrogen.  
Figure 1.11 Stereoselectivity of chiral aza-analogues 
 
     The lack of catalytic activity of catalyst 1.43b was surprising, considering its close 
similarity with HTM. To confirm this result, 5% catalyst loading was used to catalyze the 
acetylation of methanol. (Figure 1.12) The t1/2 is about 5h, which indicates that the 
catalytic activity is indeed very low. The reason for this behavior is not clear at present. 
 
12 
Figure 1.12 Catalytic activity test of compound 1.43b in acylation of methanol 
 
1.8 Synthesis of a 7-membered ring analogue of THTP 
      To explore the catalytic activity of a seven-membered ring analogue of THTP, I 
synthesized known compound 1.29 according to a slightly modified procedure from 
literature
17
. (Scheme 1.6)  
      Its activity in the MeOH-Ac2O test turned out to be lower than that of THTP itself, 
but still fairly good. In fact, compound 1.29 was comparable to DBN and far more active 
than any other bicyclic amidines and isothioureas tested in our previous studies (t1/2 ≥3.5 
h at 5 mol% catalyst loading). 
 
 
 
 
 
 
13 
Scheme 1.6 Synthesis of compound 1.29 
 
Entry Catalyst 
Catalyst 
loading 
(mol%) 
t1/2 
1 
1.29 
0.1 
1 
5h 
30min 
2 THTP 0.1 25 min
a 
3 DBN 1 40 min
a 
                                                 a
Data from previous study 
[13] 
1.9 Conclusions 
      In this chapter, several aza-analogues and a seven-membered ring analogue of THTP 
were prepared and their catalytic activities were investigated. Only one of the achiral aza-
THTPs proved to be highly active. However, for reasons that are not clear at present, its 
2-phenyl derivative 1.43b lacks catalytic activity. At the same time, the 3-phenyl isomer 
1.43c is not only catalytically active, but also shows some enantioselectivity, despite the 
fact that the phenyl group is relatively far from the reactive site. Even if aza-THTPs do 
not find any applications in catalyst design in the future, this result suggests that ABCs 
with a chiral center at the β-position merit further study. The first results obtained with 
the 7-membered THTP analogue are also encouraging enough to warrant further 
exploration.  
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Chapter 2 Development of azoles derivatives as anionic acyl transfer 
catalysts 
2.1  Introduction to anionic nucleophilic catalysis 
      The majority of acyl transfer catalysts used in organic synthesis are neutral organic 
molecules. Examples of achiral catalysts of this type are illustrated in Figure 1.4, and 
chiral ones can be found in Figure 1.2, Chapter 1. Their utility and wide popularity 
ultimately depends on their ability to react with acyl donors and transform them into 
activated intermediates, which will in turn transfer the acyl group to nucleophilic 
substrates. 
Figure 2.1 Comparison of neutral nucleophilic and anionic nucleophilic catalysis 
 
      During the development of our neutral amidine-based acyl transfer catalysts, we 
became interested in developing a new method for the catalytic, enantioselective 
acylation of amines using easily available achiral acyl donors.
1
 Anhydrides and acyl 
chlorides are unsuitable for this purpose, because they usually react with amines directly, 
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without any catalysis. On the other hand, carboxylic esters would be more attractive, 
because their background reaction with amines is extremely slow under ambient 
conditions.  However, the neutral catalysts reported previously in the literature, which 
have been successfully applied to acylation reaction using carboxylic anhydrides or acyl 
chloride as the acyl donors, can only activate highly acivated carboxylic esters. To 
address this limitation, our group developed a new concept: anionic nucleophilic catalysis, 
illustrated in Figure 2.1. 
      A priori, anionic nucleophiles are expected to be more nucleophilic than their neutral 
counterparts, and therefore better able to attack the ester group. With this in mind, one of 
my labmates, Xing Yang, examined a number of protic nucleophiles for their ability to 
activate phenyl acetate for the acylation of isopropylamine in the presence of 
stoichiometric amounts of DBU (pKa of protonated DBU is 13.28 predicted by 
SciFinder).
2
 Among the many classes of nucleophiles tested, 1,2,4-triazole proved to be 
by far the most active. On the other hand, several other azoles, which are only slightly 
structurally different, displayed much lower activities. (Figure 2.3) 
Figure 2.2 Activities of azoles compounds for aminolysis of esters 
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     This effect was attributed to the difference in their electronic properties: less electron 
deficient, and therefore less acidic, azoles would not form high concentrations of the 
reactive anionic species in the presence of DBU, while too electron-deficient azoles 
would easily ionize, but their anions would be too unreactive. 
     After some optimization studies, Xing demonstrated that, at 5-20 mol% loading, 1,2,4-
triazole anion serves as an effective acyl transfer catalyst in both aminolysis and 
transesterification of isopropenyl acetate and even completely unactivated esters, which 
require only substoichiometric amounts of DBU. Furthermore, he showed that the 
protonated counterion is not important: sodium and tetrabutylammonium salts of 1,2,4-
triazole are even more catalytically active than the DBU-triazole mixture, when used in 
appropriate solvents.  Overall, 1,2,4-triazole was judged to be a good candidate for our 
future studies on chiral anionic nucleophilic catalyst design. 
2.2 Objectives of this study 
     Upon completion of Xing’s study, we became interested in developing chiral 1,2,4-
triazole derivatives for enantioselective acylation of amines, which was our original goal. 
We quickly realized that introduction of an effective chiral directing group into the 
triazole molecule was not going to be a trivial matter. Therefore, we thought to broaden 
our knowledge of the factors influencing the catalytic activity.   
Figure 2.3 Electronic effects on the azole ring  
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     First of all, we wanted to know exactly what range of pKa values would be compatible 
with good catalytic activity. To close the gap between 1,2,4-triazole itself (pKa 10.2) and 
pyrazole (pKa 14.0), we planned to explore 1,2,4-triazole derivatives with electron-
donating substituents and pyrazole derivatives with electron-withdrawing groups. (Figure 
2.3)  
     Second, we wished to study the effect of steric hindrance. Xing had already prepared a 
series of C2-symmetrical chiral triazoles 2.6, 2.7, 2.8 (Figure 2.4) and found their 
catalytic activities to be fairly low.
3
 Therefore, we wished to explore other substitution 
patterns that might allow us to design more effective chiral catalysts. Third, we needed to 
determine what types of cations can be used in conjunction with azole anions, in addition 
to those briefly tested by Xing in his preliminary study. 
Figure 2.4 C2-symmetrical chiral triazoles 
 
2.3 Structure-activity relationship of azole derivatives 
2.3.1 The electronic effects of pyrazole derivatives on β position 
     Conveniently, several pyrazole derivatives with electron-withdrawing groups on the β 
position, such as 4-bromopyrazole (2.9), 4-chloropyrazole (2.10) and 4-nitropyrazole 
(2.11), are commercially available or can be easily synthesized. (Table 2.1)  
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Table 2.1Electronic effects on β position of pyrazole ring  
Ph Me
NH2
+
Me OR
O
Test A: 10 mol% catalyst, 
1 equiv DBU, 
R = Phenyl, CDCl3, rt
Test B: 10 mol% catalyst, 
10 mol% DBU, 
R = isopropenyl, CD3CN, rt
Ph Me
NHAc
 
entry catalyst 
Predicted 
pKa
a 
t1/2 (h) 
Test A 
t1/2 (h) 
Test B 
1 N
N
N
H 2.1 
10.18 2 2 
2 N
N
H 2.2 
14.00 14 ND 
3 N
N
H
Br
2.9 
12.71 1 2.5 
4 N
N
H
Cl
2.10 
12.71 1 ND 
5 N
N
H
O2N
2.11 
9.63 6 20 
                                              
a
 pKa predicted by SciFinder 
       Catalytic activity was tested first using phenyl acetate in CDCl3 according to the 
standard procedure developed previously by Xing. Later, the most promising catalysts 
were re-examined using isopropenyl acetate in CD3CN, so that the accumulation of 
phenolate anion does not complicate the course of the reaction.
2
 It was interesting to find 
that 4-bromopyrazole (2.9) and 4-chloropyrazole (2.10) displayed significant higher 
catalytic activity than did pyrazole itself and even a little higher than 1,2,4-triazole, as we 
expected based on their predicted pKa values (both have pKa=12.71). By contrast, the 
catalytic activity of 4-nitropyrazole (2.11) (pKa=9.63) was lower than that of 1,2,4-
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triazole, although was still higher than that of pyrazole. This result was also consistent 
with our prediction.  
2.3.2 The electronic effects on α position of pyrazole ring 
      Substituents on the β position of pyrazole discussed above allowed us to evaluate the 
electronic effects without any complications from steric hindrance. Now we wanted to 
examine the influence of electron-withdrawing groups on the α-position of pyrazole, 
where steric and other effects would also play a role. Methyl 3-pyrazolecarboxylate (2.12) 
with pKa=11.04 displayed by far the greatest catalytic activity in Test A and was equal to 
triazole in Test B (Table 2.2, entry 1). The corresponding amide which was prepared via 
a self-catalyzed aminolysis
2
 (Scheme 2.4)
 
was less reactive (entry 2). Even lower activity 
was found in disubstituted pyrazole 2.14 with pKa 13.27 (entry 3). In all these cases, the 
acetylation was presumed to occur on the nitrogen distal to the α-substituent, to avoid the 
steric interaction. Trisubstituted pyrazole 2.15 with a pKa well within “the optimal range” 
was very unreactive, as might be expected from the steric hindrance of both nitrogens. 
Surprisingly, triazole derivative 2.16 with an electron-donating substituent Proved to be a 
poor catalyst despite the promising pKa.  
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Table 2.2 Electronic effects on α position of pyrazole ring 
entry catalyst 
Predicted 
pKa 
t1/2 (h) 
Test A 
t1/2 (h) 
Test B 
1 N
H
N
MeO
O
2.12 
11.04 0.5 2 
2 N
H
N
N
O
2.13 
12.98 3 2.5 
3 
N
H
N
Br
Me
 2.14 
13.27 6 18 
4 
N
H
N
O2N
Me
Me 2.15 
10.75 96 ND 
5 N
N
H
NN
2.16 
11.9 9 ND 
4 N
H
NP
O
Me2N
NMe2
Me 2.17 
NA
a
 12 ND 
5 
P N
H
N
O
N
N
Bn
Bn 2.18 
NA
a
 6 ND 
6 
P N
H
N
O
RO
RO
R = L-Menthyl  2.19 
9.60
b
 2.5 3 
                  
        a
 pKa is not known       
b
 pKa from a diethyl ester analogue 
      With these results in hand, we began to think more specifically about introducing 
chiral groups into the pyrazole core structure. At least for now, we decided to focus on 
the α-substitution. We reasoned that if a chiral group were to be attached via an ester or 
amide linkage, it would probably be too far from the distal nitrogen where the reaction is 
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supposed to take place. It occurred to us that phosphonate esters or phosphonamides 
might be more promising, both in terms of electronic properties (stronger than their 
carbonyl counterparts) and spatial configuration. A conceptual precedent for this idea can 
be found in the use of chiral phosphoramides as both catalyst and chiral auxiliaries in 
asymmetric transformations.
4
 Three phosphorus compounds were synthesized as 
illustrated in Schemes 2.1-2.3
5, 6, 7, 8
 and tested. Most interestingly, bis-(L-menthyl) 
pyrazolephosphonate 2.19 displayed catalytic activity only slightly lower than triazole. 
Scheme 2.1 Synthesis of compound 2.17
 
 
Scheme 2.2 Synthesis of compound 2.18  
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Scheme 2.3 Synthesis of compound 2.19 
 
Scheme 2.4 Preparation of compound 2.13 via self-catalyzed aminolysis
 
 
2.4 Enantioselectivity test of menthyl phosphonate pyrazole derivative 
      Due to its good activity and ease of preparation, the bis-menthyl phosphonate 2.19 
was deemed to be an especially promising lead for developing enantioselective catalysts.  
Even though the chiral menthyl groups were not expected to provide good 
enantiodiscrimination, we decided to test the efficacy of this scaffold anyway. No ee was 
observed when 2.19 was used as a catalyst in the acetylation of α-phenethylamine with 
isopropenyl acetate. Three N-acylated derivatives of 2.19 were preformed and used as 
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stoichiometric acylating agents. Still, no enantioselectivity was observed. (Scheme 2.5) 
Due to time constraints, further study of pyrazole-based anionic catalysts was put on hold. 
Scheme 2.5 Enantioselectivies of menthyl phosphonate pyrazole derivative 
 
2.5 Variation of Counterions 
     In the studies described above, as well as Xing’s original study, DBU has used 
routinely to deprotonate azoles in situ, simply out of convenience. We already knew, 
however, that it was not optimal for catalytic activity. Therefore, we decided to examine 
several other salts of 1,2,4-triazole that might ultimately prove to be more attractive as 
catalysts for reactions that do not produce acidic byproducts. Conditions of Test B, which 
generate only acetone as byproduct were chosen for their comparison. 
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Table 2.3 Catalytic activities of 1,2,4-triazole under different bases 
 
Entry Catalyst t1/2 (h) Test B 
1 
 
2 
2 
 
2.5 
3 
 
1.5 
4 
 
2.5 
5 
 
0.5 
DBN (pKa=13.42)   TBD (pKa=14.47) 
      Relatively minor differences were found between DBU and other commonly used 
strong bases: amidine DBN and guanidine TBD (Table 2.3, entries 1-3). More 
interestingly, cesium salt of triazole demonstrated comparable activity despite the fact 
that it was only partially soluble in acetonitrile (entry 4). Finally, the most rewarding 
result was obtained in the case of potassium salt of 1, 2, 4-triazole complexed with 18-
Crown-6 (entry 5).  This salt is a stable, not very hygroscopic solid easily soluble in 
organic solvents, which should make it a convenient catalyst. Its high activity suggests 
that crown ether-chelated alkaline metal cations might be superior to DBU for 
enantioselective catalysis where low catalyst loadings are especially important. 
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2.6 Conclusions 
      In this chapter, we have demonstrated that many pyrazole derivatives are comparable 
to 1,2,4-triazole in terms of catalytic activity. Furthermore, compared to triazole, pyrazole 
offers more opportunities for structural variation and therefore might have more potential 
for the development of chiral anionic catalysts. Although enantioselective acylation of 
amines with pyrazolephosphonate ester derivatives could not be demonstrated in the 
preliminary tests, the synthetic route to such compounds has been established. This 
should permit a more systematic study in the future. In addition, we have established that 
preformed alkaline metal salts of azole anions might provide an attractive alternative to 
their DBU salts. 
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Chapter 3 Chiral Brønsted acid catalyzed enantioselective alcoholysis 
3.1 Introduction  
3.1.1 Chemistry of azlactones 
      Azlactones, or oxazolones, are an interesting class of heterocyclic compounds usually 
prepared via cyclodehydration of N-acylated α-amino acids. Their synthetic chemistry, 
including many enantioselective transformations, is remarkably rich and diverse.  Since a 
comprehensive discussion of the different modes of reactivity displayed by azlactones is 
beyond the scope of this chapter, the reader is hereby referred to a recently published 
review.
1
 We will focus our attention on only one aspect of their chemistry: 
enantioselective alcoholysis. In essence, azlactones may be thought of as cyclic 
anhydrides of as α-acylamino acids. Therefore, they are expected to react as acyl donors 
towards nucleophiles, such as alcohols or amines, producing esters or amides of the 
parent amino acid derivatives.  
Figure 3.1 Mechanism of DKR of azlactones 
 
      One especially interesting feature of chiral azlactones bearing one substituent at C4 is 
the extreme ease with which they racemize in solution. This property is due to the fact 
31 
that the enol form of azlactones is an aromatic oxazole derivative, which makes the C4 
proton unusually acidic (pKa ca. 9).
2
 Because of this rapid in situ racemization of 
azlactones, their enantioselective alcoholysis is accompanied by dynamic kinetic 
resolution (DKR) (Figure 3.1).
3
  
      As shown in Figure 3.1, the two enantiomers of azlactone are in equilibrium with 
each other through the achiral enol intermediate. If one of the enantiomers undergoes 
alcoholysis faster than the other one (under asymmetric catalysis), then the equilibrium 
will be continuously drained in its direction. If the racemization is much faster than the 
alcoholysis of the slow-reacting enantiomer, then the entire racemic starting material will 
be transformed into one enantiomer of the product. This process is known as dynamic 
kinetic resolution (DKR). Compared to the conventional kinetic resolution (KR), which 
simply converts the two enantiomers of the starting material into two different 
compounds, DKR is inherently more efficient: while KR can achieve at most 50% yield 
of either enantiomeric product, DKR can produce up to 100% theoretical yield. 
      Due to the practical importance of enantioenriched α-amino acid derivatives, catalytic 
DKR of azlactones has received considerable attention from the synthetic community. 
Enzymatic methods were originally developed
4
 years ago and continued to be optimized 
over the years. Somewhat later, approaches utilizing low-molecular weight catalysts 
began to appear. These nonenzymatic methods are reviewed in some detail in the next 
section, because they are directly relevant to the subject of my study described in this 
chapter. 
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3.1.2 Lewis acid-promoted DKR of azlactones 
     Seebach et al.
5
 reported titanium TADDOLate as a stoichiometric reagent for the 
asymmetric ring opening of azlactones. Up to 65% ee were obtained in this study.-As 
shown in Figure 3.2, titanium serves as a Lewis acidic center to activate the carbonyl 
oxygen of the azlactone substrate, while the isopropoxide group attacks the carbonyl 
carbon to provide enantioenriched ester as the product. 
Figure 3.2 DKR of azlactones promoted by Lewis acids 
 
3.1.3 DKR of azlactones catalyzed via hydrogen bonding catalysis. 
     In 1999, Hua
6
 achieved catalytic DKR of azlactones using a combination of a chiral 
diketopiperazine, cyclo-[(S)-His-(S)-Phe], with diisopropyl L-tartrate. The latter was 
presumed to activate the substrate via hydrogen bonding. However, only 39% ee was 
obtained. (Figure 3.3) 
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Figure 3.3 DKR of azlactones catalyzed via hydrogen bonding 
 
     Much better results were achieved several years later using chiral thiourea-based 
bifunctional catalysts.  Berkessel et al.
7
 obtained moderate to good enantioselectivities 
(72-85% ee) for most of the substrates examined. The highest enantioselectivity (91% ee) 
was observed for the bulkiest t-Bu-substituted substrate. Unfortunately, the yield in this 
case was rather low (16%). (Figure 3.4) 
Figure 3.4 DKR of azlactones catalyzed by chiral thiourea catalysts 
 
     Shortly thereafter, Connon et al.
8
 reported the DKR of azlactones catalyzed by the 
quinine-derived thiourea bifunctional catalysts. Moderate enantioselectivities (78-88% ee) 
were obtained for the alkyl-substituted azlactones. (Figure 3.5)  
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Figure 3.5 DKR of azlactones catalyzed by quinine-derived thiourea derivatives 
 
      According to Berkessel, the thiourea moiety is believed to activate the carbonyl group 
by double hydrogen bonding with the oxygen while the basic amine serves as a hydrogen 
bond acceptor towards the alcohol and thus directs the nucleophilic addition from the less 
hinder face of the substrate (Figure 3.6). 
Figure 3.6 Mechanism of bifunctional chiral thiourea activation 
 
3.1.4 DKR of azlactones via acyl transfer catalysis 
      Promising levels of enantioselectivity (up to 78%ee) were achieved by Fu and co-
workers in 1998 using their planar chiral DMAP derivatives as the acyl transfer catalyst.
9
 
Interestingly, they reported in their paper that addition of benzoic acid as a co-catalyst 
35 
was required, presumably to activate the azlactone. Moderate enantioselectivities were 
observed (50-60% ee) when using methanol for alcoholysis.  
Higher enantioselectivity (78% ee) was obtained using isopropanol as the nucleophile, 
but the reaction rate was extremely slow (7 days). (Figure 3.7) 
Figure 3.7 DKR of azlactones catalyzed by chiral DMAP derivatives 
 
      Higher enantioselectivities were obtained recently in our group by using our chiral 
isothiourea catalyst, (S)-BTM in combination with benzoic acid.
10
 Use of di-(1-naphthyl) 
methanol was required to achieve high enantioselectivity. Alkyl-substituted azlactones 
produced ee’s in the 80-90% range; while the corresponding aryl derivatives gave 76-96% 
ee’s.  However, some limitations of this methodology were also uncovered. Thus, 
substrates with an ortho-substituted aryl or isopropyl group at C4 failed to react. (Figure 
3.8) 
Figure 3.8 DKR of azlactones catalyzed by BTM   
 
36 
      The mechanism of acyl transfer catalysis is somewhat more complicated than those 
discussed above. As shown in Figure 3.9, three steps are involved in its catalytic cycle 
proposed for the BTM-catalyzed DKR developed in our group. In the first step, the 
substrate is activated by protonation with benzoic acid. The ring opening by the 
nucleophilic catalyst occurs in the second step to form an acylated intermediate, which 
transfers the acyl group to the alcohol in the third step. 
      The first two steps are presumed to be easily reversible. The enantioselectivity is 
determined by the third step and depends on the alcohol employed. We have proposed 
that in the transition state, there is a hydrogen bond between the benzamide group and the 
reacting carbonyl group which fixes its conformation. The R group on the substrate is 
positioned next to the C2-phenyl group on the catalyst, which is probably why bulky 
substituents, such as isopropyl or ortho-substituted aryl groups, are not tolerated.  
Figure 3.9 DKR of azlactones catalyzed by acyl transfer catalysts  
 
3.2 The purpose of this project 
      In the course of our recent studies described above, we first became aware that the 
presence of a proton source is necessary to activate azlactones towards nucleophilic 
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attack. However, no appreciable reaction was observed when benzoic acid was used by 
itself, in the absence of BTM. We hypothesized, nevertheless, that a sufficiently strong 
Brønsted acid might be able to activate azlactones enough to promote their direct 
alcoholysis without the intermediacy of a nucleophilic catalyst. A chiral Brønsted acid 
could then be used to effect DKR of azlactones via a mechanistically different alternative 
method. We were especially hopeful that BINOL phosphoric acids pioneered some years 
ago by Akiyama and Terada
11
 would be competent in this reaction. Interestingly, there 
had been no prior reports of their use to promote enantioselective acylations of any sort, 
even though they have been successfully applied to a variety of other types of asymmetric 
transformations.
12
   
3.3 DKR of azlactone catalyzed by stronger BrØnsted acid 
       To test this, idea, we reacted 2,5-diphenylazlactone (±)-1a with benzyl alcohol in the 
presence of (R)-BINOL phosphoric acid (pKa=1) which is more acidic than benzoic acid 
(pKa=4.2). The reaction went smoothly to give the expected ester, albeit in essentially 
racemic form (2% ee).  (Table 3.1).  In order to support this result and demonstrate how 
strong an acid needs to be to promote direct alcoholysis of azlactones, several achiral 
acids were tested in this reaction. As already mentioned, benzoic acid (pKa=4.2) is too 
weak to promote the reaction. However, the stronger trifluoroacetic acid (pKa=-0.25) 
resulted in 40% conversion after 24h and methanesulfonic acid (pKa=-2.6) provided 100% 
conversion.  
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Table 3.1 Alcoholysis of azlactones catalyzed by other acids 
 
Entry Acid pKa Time, h % conversion 
1 
O
O
P
O
OH
 
1
a
 16 100 
2 PhCOOH 4.2
b
 24 0 
3 TFA -0.25
b
 24 40 
4 MsOH -2.6
b
 24 100 
                           
a
 pKa from reference 
[12d]
      
b
 pKa form Evans pKa table 
     Encouraged by this result, we catalyzed the same reaction with 3,3'- bis-(9-anthryl) 
BINOL phosphoric acid. (Figure 3.10) The resulting 63% ee of the product indicated that 
we were moving in a promising direction. 
Figure 3.10 Reaction catalyzed by substituted chiral phosphoric acid   
 
3.4 Proposed mechanism of chiral phosphoric acid catalysis 
      At this point, we proposed the mechanism illustrated in Figure 3.11. As mentioned in 
the literature
12b
, chiral phosphoric acid is believed to serve as a bifunctional catalyst in 
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many cases. We surmised that the acid protonated the substrate on the nitrogen thus 
forming a close ion pair inside the chiral cavity formed by the anthracene groups; The 
phosphate anion in turn formed a hydrogen bond to the alcohol facilitating its attack on 
the azlactone carbonyl.  
Figure 3.11 Phosphoric acid served as a bifunctional catalyst 
 
3.5 Catalyst optimization 
      We began optimizing the new reaction by testing several additional 3, 3'-disubstituted 
derivatives of BINOL phosphoric acids (Table 3.2). None of them was as good as the 
initially chosen catalyst [3,3'- bis-(9-anthryl) BINOL phosphoric acid] however. Thus, we 
selected it for further studies. 
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Table 3.2 Optimization of the catalysts 
 
Entry Ar Con (%) ee (%) 
1 H 60 2 
2 Ph(S) 96 -9 
3 9-anthryl 91 63 
4 9-phenanthryl 71 34 
5 3,5-(CF3)C6H3 65 25 
6 SiPh3 32 48 
7 2,4,6-(i-Pr)3C6H2 39 34 
8 9-phenyl-anthryl 67 25 
 
3.6 Substrates variation: C2 substitution effects 
       Since the C2 substituent on azlactones forms a removable part of the product, it was 
important to optimize it early on. It seemed that the influence of para-substituents on the 
C2 phenyl on the enantioselectivity was limited (Table 3.3, entries1-3). However, the 3,5-
dimethoxyl-phenyl group lead to a substantial improvement (entry 4). Interestingly, in a 
recent study by Terada, the same C2 substituent also proved to be optimal in a different 
type of asymmetric transformation of azlactones catalyzed by chiral BrØnsted acids.
13 
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Table 3.3 Substrates variation 
 
entry Substrates (Ar) Con (%) ee (%) 
1 4-ClC6H4 84 61 
2 Ph 91 63 
3 4-MeOC6H4 91 66 
4 3,5- MeOC6H4 72 77 
 
3.7  Optimization of reaction conditions 
3.7.1 Solvent effects 
Table 3.4 Solvent effects 
entry Solvent ee (%) 
1 CDCl3 77 
2 CH2Cl2 74 
3 Benzene 54 
4 toluene 56 
5 Et2O Substrate not soluble 
6 THF -  (conversion is 35%) 
7 EtOAc -  (conversion is 32%) 
    
42 
   Several solvents were tried for this reaction. (Table 3.4) CDCl3 initially chosen to 
facilitate NMR studies was, in fact, optimal (entry 1). The solubility of substrate was low 
in Et2O (entry 5), and the conversions were very low in both THF and EtOAc (entries 6-
7). 
3.7.2 Use of desiccants  
      As described in the literature
9
, azlactone is sensitive to moisture. As shown in Figure 
3.12, a small amount of water decreased both of the reaction rate and enantioselectivity. 
Thus, addition of a drying agent was thought to be necessary.  
Figure 3.12 Variation of desiccants 
 
      The reaction rate was very slow using 4Å MS. The addition of Na2SO4 helped 
increase slightly both of the reaction rate and enantioselectivity. MgSO4 is better than 
Na2SO4, but due to the acidity of MgSO4, Na2SO4 was eventually adopted for use as the 
drying agent in this reaction. 
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3.8 Variation of alcohols 
      Further study of alcohol effects indicated that the enantioselectivity of benzyl alcohol 
is slightly better than that of methanol, isopropanol and allyl alcohol (Figure 3.13). It 
seemed that the steric repulsion or π-π interaction between the benzyl alcohol and the 
substrate or catalyst may play a role, as we expected. Thus, several substituted benzyl 
alcohols were investigated in this reaction. One of these, 4-bromobenzyl alcohol was 
found to increase both the reaction rate and enantioselectivity. Several polycyclic 
benzylic alcohols were tested next. Experimental results showed that 1-naphthyl-, 2-
naphthyl- and 1-pyrenyl-methanol all lead to significant improvement in both reaction 
rate and enantioselectivity, compared to monocyclic benzyl alcohols. 
      As a control experiment, two saturated bulky primary alcohols, were tested.  The 
enantioselectivities were comparable to some benzylic alcohols and higher than in the 
case of methanol and isopropanol. Still, they were substantially lower than those 
observed with polycyclic benzylic alcohols. These results implied that both steric bulky 
at the β-position and π-π interactions might be important for the enantioselectivity. 
Ultimately, 1-naphthyl-methanol was chosen as the optimal alcohol for the rest of our 
studies. 
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Figure 3.13 Variation of alcohols 
 
 
3.9 Reaction rate with catalysts treated and untreated by HCl 
       During the optimization process, it was interesting to find that the reaction rate was 
much faster with the catalyst washed by HCl than that purified by column 
chromatography (Silica gel, using CH2Cl2: Methanol=100:2 as the eluent). As shown in 
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Figure 3.14, the reaction was almost complete in 6 h with 5 mol% of the acid-washed 
catalyst, but took almost 2 days with the chromatographed catalyst.  
      We were interested in finding why the catalyst’s activity depended so much on the 
method of preparation. However, almost at the same time, a paper published by Ishihara 
et al.
14
 answered this question. 
Figure 3.14 Influence of acid treatment on catalyst’s activity 
 
 
      They mentioned that the catalyst purified by silica gel may contain calcium 
phosphorate salt which “may trigger unexpected excellent result” or decrease the reaction 
rate. Further study demonstrated that the catalyst purified by silica gel had similar 
catalytic activity and enantioselectivity with the calcium phosphorate. However, the 
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catalyst washed with HCl solution increased the reaction rate and decreased or even 
reversed the enantioselectivity. (Figure 3.15) The structure of calcium phosphorate salt 
was also confirmed by FAB-HRMS analysis. 
Figure 3.15 Catalyst purified by silica gel 
 
Figure 3.16 Terada’s result  
 
       Recently, Terada
15
 and co-workers reinvestigated their reactions published before 
with the catalyst washed by HCl and purified by silica gel. They agreed with Ishihara’s 
results and pointed out that the differences between the acid-washed and 
chromatographed catalysts depend on the type of reaction.  In Figure 3.16, they presented 
an example that the enantioselectivities of both catalysts were the same. 
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      The phenomenon that the acid-washed catalysts increased the reaction rate was also 
observed by several other groups.
16
 
      Thus, it became clear to us that the catalyst we had used until now was calcium 
phosphorate, not the free phosphoric acid. However, the most important thing was not the 
catalytic activity, but enantioselectivity. We worried that the latter might drop 
dramatically using the catalyst washed with HCl solution. Fortunately, experimental 
results showed that enantioselectivity decreased only slightly (from 91% to 89%) with the 
acid-washed catalyst, while the reaction rate increased dramatically. Thus, the active 
catalyst was adopted for the rest of this study.   
3.10  Substrate scope 
      After optimization of the reaction conditions, a series of representative substrates 
were investigated. As shown in Table 3.5, for the 4-phenyl substituted substrate, 89% ee 
value was obtained (entry 2). Low temperature (-20ºC) decreased the reaction rate, but 
didn’t affect the enantioselectivity (entry 3). 
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Table 3.5 Substrate scope 
 
              *Using the chromatographed catalyst       ** Using acid-washed (R)-TRIPS  
       The new method is also applicable to other 4-aryl-azlactones cases (entries 4-10), for 
which 85~92% ee values were obtained. Substrates bearing an ortho-substitued aryl 
group on C4 reacted successfully, but required a longer reaction time (24h). By contrast, 
they failed to react in the presence of the chromatographed catalyst (see above) (entries 8-
Entry Substrates (R) Time (h) Yield (%) ee (%) 
1 Ph 48 90 91 * 
2 Ph 6 89 89 
3 Ph 20 87 89  (-20°C) 
4 4-ClC6H4 12 88 85 
5 4-MeOC6H4 12 86 88 
6 3-MeOC6H4 12 82 92 
7 2-naphthyl 12 86 85 
8 2-ClC6H4 24 88 91 
9 2-MeOC6H3 24 86 89 
10 1-naphthyl 24 86 91 
11 Me 12 88 -8 
12 Me 48 88 39* 
13 i-Pr 12 84 50 
14 Me 12 85 59** 
15 i-Pr 12 83 29** 
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10). It is also worth mentioning that the previously developed BTM-catalyzed method 
was ineffective for the same types of substrates. 
     It was interesting to find that opposite enantioselectivity (−8% ee) was observed for 
the 4-methyl-azlactone when it was catalyzed by the acid-washed catalyst (entry 11). 
However, when the chromatographed catalyst was used, +39% ee was obtained (entry 12). 
This observation was consistent with what had been mentioned in Ishihara’s paper. For a 
more bulky alkyl-substituted substrate, 4-isopropyl-azlactone, 50% ee was obtained when 
it was catalyzed by the acid-washed catalyst (entry 13), but no reaction happened when 
using the catalyst purified on silica gel.  
      Still, the enantioselectivities in the case of alkyl-substituted azlactones were much 
lower than for the aryl-substituted ones.  In an effort to find a better alternative, another 
widely used catalyst, (R)-TRIPS (also washed with HCl solution), was used on these 
substrates. An encouraging result (59% ee) was obtained for the 4-methyl-azlactone 
(entry 14). However, the enantioselectivity remained low (29% ee) in the case of 4-
isopropyl-azlactone (entry 15). Testing several additional catalysts in the DKR of 4-
methyl-azlactone with benzyl alcohol (Table 3.6) did not lead to any further improvement 
relative to the use of TRIPS in CDCl3. 
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Table 3.6 Catalysts optimization of alkyl substrates 
 
Entry Catalyst ee (%) 
1 Vapol 6 
2 9-anthracenyl 2 (7 in toluene) 
3 9-phenanthryl 3 
4 3,5-(CF3)C6H3 4 
5 SiPh3 31 
6 2,4,6-(i-Pr)3C6H2 44 (24 in toluene) 
7 10-phenyl-anthryl 9 
 
3.11 A similar approach to the DKR of azlactones reported in the literature  
     Several months after our paper was published, another research group published a 
paper in Synlett using a similar method for the DKR of azlactones.
17
 (Figure 3.17) They 
put a para-t-butylphenyl group on the C2 position of the substrates and used a rather 
elaborate bulky alcohol as the nucleophile to obtain 90-96% ee values for the 4-aryl-
azlactones. Comparing their results with ours, we were happy to conclude that our 
protocol is more convenient and economical. 
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Figure 3.17 A similar approach to DKR of azlactones 
 
3.12 Acylation of racemic alcohols 
    With the achievement in the DKR of azlactones shown above, we wanted to explore a 
new idea: can a chiral secondary alcohol undergo enantioselective acylation under 
Brønsted acid catalysis?  
        As shown in Figure 3.18, (±)-4-phenyl-azlactone was subjected to alcoholysis with 2 
eq of (±)-1-naphthalenemethanol. . After 3 days (catalyst purified on silica gel was used), 
the reaction was complete. Analysis of the unreacted alcohol showed that only 14% ee 
was obtained. An analogous experiment was performed using (±)-1-indanol (7 days) 
again producing 14% ee in the unreacted alcohol. The ester products formed in both cases 
as inseparable mixtures of diastereomers and were not analyzed further. Although only 
low ee’s were obtained in these two cases, further systematic studies may lead to the 
identification of more successful substrates and conditions. 
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Figure 3.18 Acylation of racemic alcohols 
 
3.13 Brønsted acid catalyzed kinetic resolution of oxazinones 
 Encouraged by the high enatioselectivities achieved in the DKR of azlactones, we 
sought to test the application of our new method to the Kinetic Resolution of oxazinones, 
the six-membered ring analogues of azlactones.  
      Kinetic Resolution of oxazinones had already been reported by Berkessel et al.
18
 
Using their chiral thiourea as the catalyst, they obtained excellent selectivity factors. 
(Figure 3.19) 
Figure 3.19 Kinetic resolution of oxazinones reported by Berkessel’s group 
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3.13.1 Initial study   
      In the initial study, racemic 2,4-diphenyloxazinone was subjected to alcoholysis with 
0.5 eq of benzyl alcohol in the presence of all available chiral phosphoric acids. As 
shown in Table 3.7, the reaction rate was lower than that of azlactone. Several catalysts 
showed similar and low enantioselectivities (s=~3) in this reaction (entries 2, 4, 6, 7).  
Table 3.7 Kinetic Resolution of oxazinones 
 
Entry Catalyst 
Ee of 
S.M.(% ) 
Ee of ester 
(% ) 
s Con. (%) 
1 3,5-(CF3)C6H3 3 11 1.3 21 
2 9-phenanthryl 21 41 2.9 34 
3 SiPh3 4 1 1.0 80 
4 2,4,6-(i-Pr)3C6H2 23 38 2.8 38 
5 Ph 5 6 1.2 45 
6 9-anthracenyl 30 41 3.2 42 
7 9-phenyl-anthryl 30 38 2.9 44 
 
3.13.2 Optimization of solvents  
      Because 9-antracenyl substituted BINOL phosphoric acid was available in large 
amount in our lab, it was used to optimize the reaction condition in the following study. 
As shown in Table 3.8, some improvement was achieved by carrying out the reaction in 
toluene or, even better, in a 1:3 CDCl3-toluene mixture. 
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Table 3.8 Solvent effects 
 
Entry solvent 
Ee of S.M. 
(%) 
Ee of ester 
(%) 
s 
Conversion 
(%) 
1 CD3Cl 30 41 3.2 42 
2 toluene 39 52 4.6 43 
3 CD3Cl/toluene=1/3 47 54 5.2 47 
 
3.13.3  Alcohol effects 
     In the next step, several alcohols were tried in this reaction. As shown in Table 3.9, a 
small alcohol, methanol seems to be better than benzyl alcohol (entries 1-2). The 
secondary alcohol, isopropanol is much better than methanol under the same conditions 
(entries 4 and 2). An additional experiment showed that methanol achieves higher 
enanitoselectivity (s=9.2) in a mixture solvent (CD3Cl/toluene=1/3) at 0ºC (entry 3). 
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Table 3.9 Alcohol effects 
 
Entry Alcohol solvent 
Ee of 
S.M. (%) 
Ee of ester 
(%) 
s 
Conversion 
(%) 
1 BnOH toluene 39 52 4.6 43 
2 MeOH toluene 61 58 6.7 51 
3 MeOH 
CDCl3/toluene=1/3 
(0ºC,48h) 
40 72 9.2 36 
4 i-PrOH toluene 60 67 9.2 47 
3.13.4 Optimization of C2 substituent on the substrate 
      At the same time, the substitution effects on the substrates were also investigated. As 
shown in Table 3.10, replacement of the C2 phenyl group with 3,5-dimethoxyphenyl 
made no difference (entries1-2). However, some improvement was observed with p-
chlorophenyl (entry 3). At this point, seeing that variation of several structural parameters 
and reaction conditions produces at best incremental increases in enantioselectivity, we 
decided to put this study on hold 
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Table 3.10 C2 substituent effects 
 
Entry R= 
Ee of S.M. 
(%) 
Ee of ester 
(%) 
s 
Conversion 
(%) 
1 Ph 30 41 3.2 42 
2 3,5-(MeO)2Ph 27 41 3.1 40 
3 4-ClPh 47 54 5.3 47 
 
3.14 Conclusions 
      Chiral BrØnsted acid catalysis has been applied to enantioselective acylation reactions 
for the first time. Its application to the Dynamic Kinetic Resolution of has been especially 
fruitful producing high yields and 85~92% ee values for the aryl-sbustituted-azlactones. 
Kinetic resolution of oxazinones under similar conditions was only modestly successful, 
giving a maximum selectivity factor of 9.  Very low enantioselectivities were also 
obtained in a preliminary study on the KR of alcohols. However, these results still give us 
hope that new enantioselective acylation processes amenable to chiral BrØnsted acid 
catalysis will be found in the future. 
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Chapter 4 Experimental  
4.1 General. 
     Solvents used for chromatography were ACS or HPLC grade, as appropriate. 
Reactions were followed by thin layer chromatography (TLC) and by 
1
HNMR. EM 
Science 60F silica gel plates were used for TLC analyses. Flash column chromatography 
was performed over ICN Ecochrom silica gel (32-63 mm). HPLC analyses were 
performed on a Shimadzu LC system using Chiralcel OD-H, Chiralpak AD and 
Chiralpak AD-H analytical chiral stationary phase columns (4.6x250 mm, Chiral 
Technologies, Inc.). 
1
H NMR and 
13
C NMR spectra were recorded on a Mercury 300 
MHz Varian spectrometer. The chemical shifts are reported as the values (ppm) relative 
to TMS using residual CHCl3 peak (7.26 ppm) as the reference. High-Resolution mass 
spectral analyses were performed at Washington University MS Center on a Kratos MS-
50TA spectrometer using Electro Spray Ionization (ESI) method. Melting points were 
measured on a Mel-Temp II capillary melting point apparatus. Infrared spectra were 
recorded on a Perkin-Elmer Spectrum Bx FTIR spectrophotometer using potassium 
bromide plates. 
4.2 Synthesis and exploration of THTP analogue for acyl transfer catalysis 
4.2.1 Preparation of THTP analogues 
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     To a solution of Bromoethylamine hydrobromide (2.05 g, 10mmol) in 10ml MeOH, 
was added a solution of methylhydrazine (2.11 ml, 40 mmol) at room temperature, the 
mixture was stirred at reflux for 7h, then cooled to room temperature, kept overnight. A 
solution of MeONa (1.35 g, 25 mmol) in 10 ml MeOH was added, stirred for 3h at room 
temperature. The mixture was concentrated to about 5ml, filtered to remove off the 
precipitate. The filtrate was concentrated to give a colorless liquid which was put to the 
next step without purification. To this liquid, was added 7ml of 50% EtOH solution and 
1.5ml of CS2 at room temperature. The mixture was stirred at refluxed overnight, cooled 
to room temperature. 2ml of conc. HCl was added, and kept at room temperature for 
overnight, a precipitate was formed, filtered to give a pale yellow powder which was 
washed with acetone to give 0.568g pale yellow powder, yield 43%. 
1
HNMR (300 MHz, DMSO-d6):9.34s, 1H), 8.10(s, 1H), 3.21-3.16(m, 2H), 2.85(t, 
J=6Hz, 2H), 2.46(s, 3H); 
13
CNMR (75 MHz, DMSO-d6):  
MS: HR-ESI calculated for C4H9N3SH (M+H
+
) m/z: 132.0590, found m/z: 132.0589; 
 
     The mixture of compound 1.32 (262 mg, 2 mmol), 1,2-dibromoethane (0.15 ml, 1.8 
mmol) and Na2CO3(0.636 g, 6 mmol) in 30ml of MeOH was stirred at reflux overnight, 
TLC showed that there was still a little amount of compound 1. Additional 1,2-
dibromoethane (0.15 ml, 1.8 mmol) was added, continued to stir for 3h, TLC showed that 
the reaction was completed. The solvent was removed off to give a brown liquid which 
was dissolved in CH2Cl2, the organic phase was washed with sat. NaHCO3 solution, 
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water and brine, then dried by Na2SO4. The crude product was purified by column 
chromatography (Neutral Al2O3, EtOAc) to give 155mg brown liquid, yield 50%. 
1
HNMR (300 MHz, CDCl3): 3.35(t, J=6Hz, 2H), 3.37(t, J=6Hz, 2H), 3.01(t, J=6Hz, 
2H), 2.74(t, J=6Hz, 2H), 2.48(s, 3H); 
13
CNMR (75MHz, CDCl3): δ 158.54, 53.10, 47.77, 
44.19, 40.17, 24.17; IR: 3399.2, 2947.1, 2860.2, 1608.5; MS: HR-ESI calculated for 
C6H11N3SH (M+H
+
) m/z:158.0746, found m/z:158.0745; 
HMBC, HMQC, NOE: (See appendix) 
 
     The mixture of compound 1.32 (131 mg, 1 mmol), Na2CO3 (0.318 g, 3 mmol) and 
chloro acetone (96 ul, 1.2 mmol) in 20ml of EtOH was stirred at reflux overnight. The 
solvent was removed off to give a brown liquid which was dissolved in CH2Cl2. The 
organic phase was washed with sat. NaHCO3, water and brine, dried by Na2SO4, purified 
by column chromatography (Neutral Al2O3, EtOAc) to give 80mg brown liquid, yield 
47%. 
1
HNMR (300 MHz, CDCl3): δ5.26(s, 1H), 3.75(t, J=4.5Hz, 2H), 2.74(t, J=4.5Hz, 2H), 
2.66(s, 3H); 
13
CNMR (75MHz, CDCl3): 151.95, 134.15, 91.77, 48.12, 47.44, 43.99, 
13.61; IR: 2930.39, 1726.7, 1262.3, 749.2; MS: HR-ESI calculated for 
C7H11N3SH(M+H
+
) m/z:170.0746, found m/z: 170.0745; 
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     The mixture of compound 1.32 (50 mg, 0.38 mmol) and bromo phenyl acetone(76 mg, 
0.38 mmol) in 2 ml of EtOH was stirred at reflux overnight, the solvent was removed off 
to give a brown liquid which was dissolved in CH2Cl2, washed with sat. NaHCO3, water 
and brine, dried by Na2SO4, purified by column chromatography (Neutral Al2O3, EtOAc) 
to give 35 mg brown liquid, yield 40%. 
1
HNMR (300 MHz, CDCl3): 7.38-7.30(m, 5H), 5.65(s, 1H), 3.73(t, J=6Hz, 2H), 2.75(s, 
3H), 2.67(t, J=6Hz, 2H); 
13
CNMR (75MHz, CDCl3): 152.30, 140.32, 130.70, 129.24, 
129.01, 128.06; 95.77, 48.28, 47.48, 47.21; IR: 2953.1, 1605.6, 1358.6, 765.9; MS: HR-
ESI calculated for C12H13N3SH (M+H
+
) m/z: 232.0908, found m/z: 232.0902; 
 
     The mixture of 2-(aziridin-1-yl)ethanol (0.4 ml, 5 mmol), methylhydrazine (2.1 ml, 40 
mmol) and 50 mg NH4Cl was stirred at reflux overnight, the solvent and excess 
methylhydrazine were removed by rotavapor to give a colorless residue. To this residue, 
were added 20 ml CH2Cl2 and 2ml CS2, the mixture was stirred at reflux overnight. The 
solvent and excess CS2 were removed by rotavapor to give a brown liquid, 20 ml CH2Cl2 
was added, the solution was washed with sat. NaHCO3, water and brine, dried by Na2SO4, 
purified by column chromatography (Neutral Al2O3, EtOAc) to give 210 mg brown liquid, 
yield 27% for three steps. 
1
HNMR (300 MHz, CDCl3): 3.40(t, J=7.5Hz, 2H); 3.32(t, J=6Hz, 2H); 3.06(t, J=6Hz, 
2H); 2.64(t, J=6Hz, 2H); 2.59(s, 3H); 
13
CNMR (75 MHz, CDCl3): 150.27, 53.90, 48.95, 
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47.24, 46.43, 27.60; IR: 3390.4, 2949.1, 2858.7, 1613.3; MS: HR-ESI calculated for 
C6H11N3SH (M+H
+
) m/z: 158.0746, found m/z: 158.0745; 
HMBC, HMQC, NOE: (See appendix) 
 
     To a solution of Compound 1.39 (2.099 g, 6.0 mmol) in 30 ml THF, was added a 
solution of MeNHNH2 (1.10 ml, 21 mmol) at 0°C, the mixture was warmed up to room 
temperature and stirred overnight, TLC showed that the reaction was completed. The 
solvent was removed off to give a brown residue. To this residue, was added 30ml 
CH3CN, PhSH (1.0 ml, 10 mmol) and K2CO3 (1.60 g, 11.6 mmol), the mixture was kept 
stirring at 50°C for 3h or until TLC showed that the reaction was completed. The mixture 
was filtered, the filtrate was concentrated to give a brown residue. To this residue, was 
added 20 ml 50% EtOH and 10 ml of CS2. The mixture was stirred at reflux overnight, 
the solvent and excess CS2 was removed to give a residue, 20 ml of CH2Cl2 was added, 
the organic layer was washed with water, dried by Na2SO4, concentrated to give a crude 
product which was purified by column chromatography (Silica gel, EtOAc: Hexane=1:2) 
to give 400 mg brown solid which was a mixture of compound 1.42b and 1.42c, yield 28% 
for three steps.   
     To a mixture of 1.42b and 1.42c (27 mg, 0.13 mmol) in 3 ml EtOH, was added a 
solution of 1, 2-dibromoethane (22 µl, 0.26 mmol) and Na2CO3 (165 mg, 1.56 mmol), the 
mixture was stirred at reflux overnight, TLC showed that the reaction was completed. 
The solvent was removed to give a residue which was purified by column 
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chromatography (Silica gel, EtOAc: Methanol=4:1) to give 9mg of compound 1.43b and 
10mg of compound 1.43c respectively, yield 63%. 
Characterization of compound 1.43b: 
1
HNMR (600 MHz, CDCl3): 7.30-7.19 (m, 5H), 4.45-4.43(m, 1H), 3.86-3.83(m, 1H), 
3.64-3.59(m, 1H), 3.30-3.25(m, 1H), 3.07-3.00(m, 2H), 2.65(s, 3H), 2.60-2.56(m, 1H);  
13
CNMR (150MHz, CDCl3): δ 159.79, 139.56, 128.58, 127.49, 127.01, 55.83, 52.96, 
51.15, 44.64, 24.83; IR: 2922.1, 1604.2, 1580.5, 700.9; MS: HR-ESI calculated for 
C12H16N3SH (M+H
+
) m/z: 234.1065, found m/z: 234.1060; HMBC, HMQC, NOE: (See 
appendix) 
Characterization of compound 1.43c: 
1
HNMR (600 MHz, CDCl3): 7.33-7.18 (m, 5H), 3.94-3.90(m, 2H), 3.73-3.69(m, 1H), 
3.66-3.63(m, 1H), 3.35-3.31(m, 1H), 3.06-3.02(m, 1H), 2.89-2.86(m, 1H), 2.52(s, 3H);  
13
CNMR (150 MHz, CDCl3): δ 158.71, 138.32, 128.40, 127.98, 127.52, 59.21, 52.72, 
42.58, 41.85, 24.21; IR: 2919.1, 2341.6, 1726.8, 1612.5, 739.91; MS: HR-ESI calculated 
for C12H16N3SH (M+H
+
) m/z: 234.1065, found m/z: 234.1059; HMBC, HMQC, NOE: 
(See appendix) 
 
     Compound 1.44 (2.09 g, 10 mmol) was dissolved in 10 ml H2O, 5 ml of 50% NaOH 
solution was added, then the mixture was extracted with CH2Cl2, dried by Na2SO4, 
concentrated to give a brown liquid. To this liquid was added 20 ml EtOH and CS2 (1.20 
ml, 20 mmol). The mixture was stirred at room temperature overnight, the solvent was 
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removed to give a sticky solid. To this solid, was added 20 ml MeOCH2CH2OH. The 
mixture was stirred at reflux for 3h, cooled to room temperature, filtered to give 1.20 g 
white solid, yield 67%. 
1
HNMR (300 MHz, DMSO-d6): 8.13(s, 2H), 7.30-7.21(m, 4H), 4.34(d, J=6Hz, 4H); 
13
CNMR (75 0MHz, DMSO-d6): 179.44, 138.54, 128.77, 128.03, 46.11; 
MS: HR-ESI calculated for C9H10N2SH (M+H
+
) m/z: 179.0643, found m/z: 179.0639; 
 
     The mixture of compound 1.45 (89 mg, 0.5 mmol) and chloroacetone(48 µl, 0.6 mmol) 
in 5 ml MeOCH2CH2OH was stirred at reflux for 3h. Then the mixture was cooled, the 
solvent was removed to give a brown liquid which was dissolved in CH2Cl2, the solution 
was washed with sat. NaHCO3 solution, dried by Na2SO4, purified by column 
chromatography (Neutral Al2O3, EtOAc) to give 88 mg pale yellow solid, yield 81%. 
1
HNMR (300 MHz, CDCl3):  7.34-7.17(m, 4H), 5.30(s, 1H), 4.89(s, 2H), 4.75(s, 2H), 
2.05(s, 3H); 
13
CNMR (300MHz, CDCl3): 161.63, 140.81, 134.60, 134.04, 129.22, 
128.34, 127.94, 127.56, 93.41, 51.52, 48.16, 15.94; 
 
MS: HR-ESI calculated for C12H12N2SH (M+H
+
) m/z: 217.0799, found m/z: 217.0794; 
4.2.2 Catalytic activities of THTP analogues for acylation of methanol 
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Stock solution A: 0.25 M Ac2O (24 µl, 0.25 mmol) in 1.0 ml CDCl3. 
Stock solution B: 0.25 M MeOH (10 µl, 0.25 mmol) and 0.25 M DIEA (44 µl, 0.25 mmol) 
in 1.0 ml CDCl3. 
Stock solution catalyst (1.20): catalyst (1.20) (64 mg, 0.407 mmol) was dissolved in 8.14 
ml CDCl3 to make catalyst solution (1) (0.05 M).  To 0.50 ml of catalyst solution (1), was 
added 0.50 ml of CDCl3 to make the Stock solution catalyst (1.20) (0.025 M). 
     The test was carried out by mixing 0.40 mL aliquots of stock solutions A, Stock 
solution B and 0.20 ml of Stock solution catalyst (1.20) at room temperature and 
monitoring reaction progress by 
1
H NMR. The time required to reach 50% conversion of 
MeOH into MeOAc was recorded as t1/2 in Table 1.1. 
Stock solution catalyst (1.36) and catalyst (1.37) were prepared and tested according to 
the similar procedure. Catalysts (1.19) and (1.29) with different catalyst loading was 
tested according to the similar procedure. 
4.2.3 Kinetic resolution of secondary alcohol catalyzed by chiral aza-analogues of 
THTP 
 
Stock solution catalyst: To catalyst 1.43c (13 mg, 0.056 mmol), was added 2.24 ml 
CDCl3 to make catalyst solution A (0.025 M). To 0.20 ml of catalyst solution A, was 
added 1.80 ml CDCl3 to make 2.0 ml of catalyst solution B (0.0025 M). 
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     To this 2.0 ml of catalyst solution B was added (±)-1-Phenylpropanol (68 µl, 0.5 
mmol), propionic anhydride (48 µl, 0.375 mmol) and i-Pr2Net (65 µl, 0.375 mmol) at 
room temperature. The reaction was monitored by 
1
HNMR at room temperature by 
comparing integration values of peaks at δ 4.6 ppm and δ 5.7 ppm and stopped by 
pouring the contents into a vial with MeOH upon reaching conversion of 45-50%. The 
workup and HPLC analysis followed the standard procedure. 
Time # eeE % eeA % CHPLC % s CAVG % sAVG 
1.5h 
1 55 46 45 5.4 
46 5.5 
2 56 48 46 5.6 
4.3  Development of azoles derivatives for acyl transfer catalysis 
4.3.1 General procedure for catalytic activity of catalysts 
 
Stock solution A: 0.4 M of phenyl acetate (253 µl, 2 mmol) and 0.4 M of α-
phenethylamine (256 µl, 2 mmol) in 5.0 ml of CDCl3. 
Stock solution catalyst: 0.04M of catalyst (0.2mmol) in 5.0ml of CDCl3. 
     The test was carried out by mixing 0.50 ml aliquots of stock solutions A and catalyst 
at room temperature and monitoring reaction progress by 
1
HNMR. The time required to 
reach 50% conversion of α-phenethylamine into N-α-phenethylacetamide was recorded 
as t1/2. 
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4.3.2 Catalytic activities study by using isopropenyl acetate as acyl donor   
 
Stock solution catalyst: 0.40 M of 1,2,4-triazole (55 mg, 0.80 mmol) and 0.40 M DBU 
(0.80 mmol, 120 µl) in 2 ml CDCl3.  
Stock solution of other catalysts can be prepared according to the similar procedure. 
     To 1ml of CD3CN, were added isopropenyl acetate (22 µl, 0.20 mmol), α-
phenethylamine (26 µl, 0.20 mmol) and 50 µl Stock solution catalyst. Conversion of α-
phenethylamine into N-phenethylacetamide was monitored by 
1
HNMR until it reached its 
50%.  
4.3.3 Catalytic activities of 1,2,4-triazole under different bases 
 
Stock solution catalyst: 0.40 M of 1,2,4-triazole (55 mg, 0.80 mmol) and 0.40 M of base 
(120 µl  of DBU, or 99 µl of DBN or 111 mg of  TBD) in 2 ml CDCl3. 
     Catalytic activity test was carried out with the same procedure as that in 4.3.2. 
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4.3.4 Catalytic activity of potassium 18-6-crown ether triazolide 
 
Stock solution catalyst: 0.40 M of potassium 18-6-crown ether triazolide (15 mg, 0.04 
mmol) in 100 µl CDCl3. 
     Catalytic activity test was carried out with the same procedure as that in 4.3.2. 
4.3.5 Catalytic activity of Cesium triazolide 
 
     To 1ml of CD3CN, were added isopropenyl acetate (22 µl, 0.20 mmol), α-
phenethylamine (26 µl, 0.20 mmol) and Cesium triazolide (4 mg, 0.02 mmol) at room 
temperature. Conversion of α-phenethylamine into N-phenethylacetamide was monitored 
by 
1
HNMR until it reached its 50%.  
4.3.6 Preparation of Phosphoramide and phosphorate pyrazole derivatives  
 
 
70 
     To a solution of PCl3 (0.88 ml, 10 mmol) protected with Ar, was added a solution of 
HMPT (3.64 ml, 20 mmol) at 0ºC, the mixture was kept stirring for 2h. 30 ml of toluene 
was added, a solution of propargyl alcohol (1.75 ml, 30 mmol) and Et3N (4.20 ml, 30 
mmol) was added at 0ºC. The mixture was warmed up to room temperature, stirred at 
room temperature for 2h, then was stirred at 50 ºC for 1h, filtered to remove the 
precipitate. The filtrate was concentrated, purified by column chromatography (silica gel 
EtOAc:MeOH=10:1) to give 2.88 g pale yellow to colorless liquid which was put to the 
next step immediately. To a solution of this Allene phosphoramide 2.23 (0.23 g, 1.36 
mmol) in 8 ml Et2O was added a solution of CH2N2 (2.04 mmol) solution at 0ºC. The 
mixture was kept at 0ºC for 6 days, NMR showed that the conversion was about 60%. 
The solution was concentrated to give sticky crude product which was purified by 
column chromatography (silica gel EtOAc:MeOH=5:1) to give 50 mg of white solid. 
1
HNMR (600 MHz, CDCl3):7.46(s, 1H), 2.67(s, 6H), 2.64(s, 6H), 2.20(s, 3H);  
13
CNMR (150MHz, CDCl3): 138.56, 131.79, 120.84, 35.88, 9.52; IR: 2930, 2359, 
1296, 1169, 982, 743; MS: HR-ESI calculated for C8H17N4OPH (M+H
+
) m/z: 217.1218, 
found m/z: 217.1216; HMBC, HMQC: (See appendix) 
 
     To a solution of diamine 2.25 (1.808 g, 7.5 mmol) in 20 ml CH2Cl2, was added a 
solution of POCl3 dropwise at 0ºC, the mixture was warmed up to room temperature, kept 
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stirring overnight, filtered. The filtrated was concentrated to give a residue which was 
dissolved in Et2O, filtered again. The filtrate was concentrated to give a pale yellow 
liquid as the crude product, then the crude product was purified by column 
chromatography (silica gel Hexane:EtOAc=3:1) to give 1.908 g colorless liquid as the 
product which was put the next step immediately, yield 79%.  
     To a solution of 1-(pyrrolidin-1-ylmethyl)-1H-pyrazole (0.302 g, 2 mmol) in 10 ml 
anhydride THF, was added a solution of n-BuLi (0.96 ml, 2.4 mmol) at -78 ºC, then the 
mixture was stirred for 1h, a solution of phosphoramide chloride compound 2.26 (0.641 g, 
2 mmol) in 5 ml THF was added at -78 ºC. The mixture was warmed up to room 
temperature, kept stirring overnight. Then the reaction was quenched with H2O, extracted 
with ethyl acetate, washed with water and brine, dried by Na2SO4, concentrated to give a 
yellow sticky liquid as the crude product which was purified by column 
chromatography(Silica gel EtOAc:Methanol=10:1 to give 116 mg white powder as the 
product, yield 16%. 
1
HNMR (600 MHz, CDCl3): 8.13(s, 1H), 7.21-7.10(m, 10H), 6.79(s, 1H), 4.16-3.81(m, 
4H), 3.29-3.05(m, 4H); 
13
CNMR (150 MHz, CDCl3): 154.28, 140.12, 139.80, 138.83, 
131.23, 131.08, 130.71, 130.35, 130.04, 115.45, 51.75, 51.25, 47.40, 46.64; IR: 2857, 
1495, 1454, 1214, 1150, 728; MS: HR-ESI calculated for C19H21N4OPH (M+H
+
) m/z: 
353.1531, found m/z: 353.1526; 
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     To a mixture of menthol (3.018 g, 19.3 mmol), Et3N (3.23 ml, 23.2 mmol) and DMAP 
(0.236g, 1.93 mmol) in 30 ml CH2Cl2, was added a solution of POCl3 (0.89 ml, 9.7 mmol) 
at 0 ºC, the mixture was warmed up to room temperature, kept stirring overnight. The 
mixture was washed with water and brine, dried by Na2SO4, concentrated to give a brown 
liquid as the crude product which was purified by column chromatography ( Silica gel, 
EtOAc:Hexane=1:10) to give 2.942 g colorless liquid as the product, yield 77%. This 
compound was put to the next step immediately. 
 
     To a solution of compound 2.30 (152 mg, 1 mmol) in 5 ml THF, was added a solution 
of n-BuLi at -78 ºC, the mixture was kept stirring at -78 ºC for 2.5h. A solution of 
compound 2.28 (0.393 g, 1 mmol) in 5 ml THF was added. The mixture was warmed up 
to room temperature, kept stirring overnight. The reaction was quenched with water, the 
mixture was extracted with ethyl acetate, the organic phase was washed with water and 
brine, dried by Na2SO4, concentrated to give a brown liquid as the crude product which 
was purified by column chromatography(Silica gel EtOAc:Hexane=1:10) to give 0.33 g 
colorless liquid, yield 65%.  
     To a solution of compound 2.29 (0.240 g, 0.472 mmol) in 5 ml MeOH, was added 2N 
HCl solution drop by drop to adjust the pH=2, the mixture was kept stirring for 2h, TLC 
indicated that the reaction was completed, a solution of sat. NaHCO3 was added to adjust 
the pH=7, then the solvent was removed off to give a residue. 20 ml of ethyl acetate was 
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added, the solution was washed with water and brine, dried by Na2SO4, concentrated to 
give 0.176 g white powder as the product, yield 95%. 
1
HNMR (300 MHz, CDCl3): 7.94(s, 1H), 6.65(s, 1H), 4.38-4.27(m, 1H), 4.17-4.06(m, 
1H), 2.36(d, J=12Hz, 1H), 2.30(m, 1H), 2.05(d, J=12Hz, 1H), 1.91-1.86(m, 1H), 1.66-
1.54(m, 4H), 1.40-0.72(m, 25H), 0.40(d, J=6Hz, 3H); 
13
CNMR (75MHz, CDCl3): δ 
110.3, 78.5, 78.0, 48.8, 43.7, 43.0, 34.3, 31.7, 25.6, 22.1, 21.1, 16.0, 15.5; IR: 2954, 1726, 
1456, 1231, 991; MS: HR-ESI calculated for C23H41N2O3PNa (M+Na
+
) m/z: 447.2752, 
found m/z: 447.2749; HMBC, HMQC: (See appendix) 
 
      A mixture of compound 2.21 (189 mg, 1.5 mmol) and 2.31 (180 µl, 1.8 mmol) was 
heated at 100°C overnight. The product was purified by column chromatography (EtOAc: 
Hexane=2:1) to give 150 mg white powder as the product, yield 56% 
1
HNMR (300 MHz, CDCl3): 7.56(s, 1H), 3.37(s, 4H), 1.65(s, 6H); 
13
CNMR (75MHz, 
CDCl3): δ 106.8, 48.4, 43.9, 26.8, 25.9, 24.8; IR: 3205, 1601, 1507, 1214; MS: HR-ESI 
calculated for C9H13N3OH (M+H
+
) m/z: 180.1131, found m/z: 180.1153; 
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4.3.7 Enantioselectivies of menthyl phosphorate pyrazole derivative 
 
     The mixture of compound 2.19 (176 mg, 0.41 mmol), 2-Naphthoyl chloride (79 mg, 
0.41 mmol) and Et3N (69 µl, 0.5 mmol) in 5 ml CH2Cl2 was stirred at room temperature 
overnight, TLC indicated that the reaction was completed. The solvent was removed to 
give a residue. To this residue was added Et2O, the mixture was filtered to removed off 
the triethylammonium hydrochloride salt. The filtrate was concentrated to give 0.246 g 
white powder. 
      To a solution of compound 2.32 in 5 ml CH2Cl2, was added a solution of α-
phenethylamine (159 µl, 1.23 mmol) at room temperature. The mixture was stirred for 1h, 
TLC showed that the reaction was completed. The mixture was concentrate to give a 
residue which was purified by column chromatography (Silica gel, EtOAc:Hexane=1:4) 
to give a white solid as the product. HPLC analysis showed that 0% ee was obtained.  
     The similar procedure was applied to the reactions using 2,2-Diphenylacetyl chloride 
and Isobutanoyl chloride as the acylating agents. 
4.4 Chiral Brønsted Acid Catalyzed Dynamic Kinetic Resolution of Azlactones  
4.4.1 Synthesis of new catalyst  
(R)-3,3'-bis-(9-phenylanthracen-10-yl)-2,2'-dihydroxy-1,1'-binapthyl. 
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     To a mixture of (R)-3,3'-diiodo-2,2'-dimethoxy-1,1'-binapthyl[1a] (297 mg, 0.53 
mmol), 9-phenylanthracen-10-ylboronic acid[3] (650 mg, 2.18 mmol), Pd(PPh3)4 (66 mg, 
0.053 mmol) and Cs2CO3 (1.04 g, 3.18 mmol) was added 32 mL of degassed aqueous 
1,2-dimethoxyethane (DME/H2O=3/1) under argon. Then the mixture was stirred under 
reflux for 24 h, cooled to roomtemperature, extracted with CH2Cl2, filtered through Celite, 
washed with saturated aqueousNH4Cl solution, water, and brine, dried with Na2SO4 and 
concentrated on a rotary evaporator. The resulting crude intermediate was dissolved in 20 
mL of CH2Cl2 and treated at 0 ºC with BBr3 (0.35 mL, 3.71 mmol). The reaction mixture 
was allowed to warm to room temperature and stirred overnight. It was then quenched 
with water, washed with saturated aqueous NaHCO3, water, and brine, dried by Na2SO4, 
and rotary evaporated. Column chromatography (Hexane/EtOAc = 20:1) gave 0.35 g of 
beige powder (83% yield). 
1
HNMR (300 MHz, CDCl3):δ 8.10 (s, 2H), 7.98-7.92 (m, 4H), 
7.78-7.71 (m, 6H), 7.65-7.37 (m, 20H), 7.34-7.23 (m, 4H) ; 
13
CNMR (75 MHz, CDCl3): 
δ 151.34, 139.07, 138.59, 134.21, 133.47, 131.48, 131.06, 130.77,130.72, 130.36, 130.31, 
129.62, 128.76, 128.67, 127.82, 127.72, 127.68, 127.63, 127.52, 126.50, 126.43, 126.12, 
125.49, 125.19, 124.56, 113.77; IR (KBr, cm-1) 3529, 3059, 1497, 1438, 1379,1259, 
1208, 1091, 1025, 912, 770, 747, 702,611. MS: HR-ESI calculated for C60H38O2 
[M+Na]:813.2764, found: 813.2763. [α]D = +69.7° (c 0.4, CH2Cl2) 
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(R)-3,3'-bis-(9-phenylanthracen-10-yl)-1,1'-binapthyl-2,2'-diyl-phosphoric acid. 
 
     To a solution of the BINOL derivative prepared above (100 mg, 0.126 mmol) in 15 
mL of CH2Cl2 stirring at 0 ºC was added Et3N (88 μl, 0.630 mmol), followed by POCl3 
(18 μl, 0.190 mmol), and the mixture was allowed to warm to room temperature and 
stirred overnight, whereupon the reaction was complete by TLC. The mixture was treated 
with 2 mL of Et3N and 10 mL of H2O stirred for one more day and acidified with 6N HCl 
to adjust the pH to 2. After stirring for 2h, the mixture was washed with H2O and brine, 
dried by Na2SO4, and rotary evaporated. Column chromatography 
(CH2Cl2/MeOH=100:1 to 100:2) yielded 85 mg of the product as pale orange powder (79% 
yield). 
1
HNMR (300 MHz, CDCl3): δ 7.97 (s, 2H), 7.90 (d, J=7.8 Hz, 2H), 7.82 (d, 
J=8.4 Hz, 2H), 7.71 (d, J=8.1 Hz, 2H), 7.56-7.18 (m, 20H), 7.07-7.05 (m, 4H), 6.75-6.70 
(m, 2H), 6.47-6.44 (m, 2H); 
13
CNMR (75 MHz, CDCl3): δ 148.19, 138.98, 137.60, 
133.51, 133.24, 132.83, 131.56, 131.40, 130.53, 130.23, 129.68, 129.61, 128.75, 128.58, 
127.80, 127.43, 127.17, 127.06, 126.51, 126.24, 126.14, 125.90, 125.30, 125.05, 124.60, 
123.27; IR (KBr, cm-1) 3629, 3300, 3061, 2360, 1599, 1496, 1441, 1381, 1254, 1110, 
1097, 911, 771, 744, 703. MS: HR-ESI calculated for C60H37O4P [M+Na]: 875.2322, 
found: 875.2322. [α]D= +119.1° (c 0.96, CH2Cl2) 
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4.4.2 Optimization of the DKR procedure 
 
     To a mixture of a freshly prepared azlactone substrate (0.10 mmol), an alcohol 
indicated (0.10 mmol) and ca. 50 mg of anhydrous sodium sulfate, was added a solution 
of a catalyst (0.005 mmol) in 1 mL of a solvent. The reaction mixture was stirred at room 
temperature for 2 days, while the reaction progress was monitored by 
1
H NMR and/or 
TLC. After the reaction was complete, the mixture was applied directly to a silica gel 
column and eluted with hexane/CH2Cl2/EtOAc (50:15:15). Enantiomeric excess was 
determined by direct HPLC analysis of the ester product. 
4.4.3 Comparison of untreated and activated forms of catalyst 
     Untreated catalyst. Catalyst was purified by chromatography (CH2Cl2/MeOH = 
100:2). Solvent removal left yellow, compact residue, which was taken up in CH2Cl2, 
diluted with hexanes and evaporated again to dryness to produce flocculent, off-white 
powder. 
     Acid-washed catalyst. A solution of the purified catalyst in CH2Cl2 (see above) was 
shaken in a separatory funnel with 4M aqueous HCl, separated from the aqueous layer, 
dried over Na2SO4, diluted with hexane and evaporated to dryness. 
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     Catalytic activity measurements. Stock solutions of both forms of catalyst in CDCl3 
(0.005 M) were prepared. These were added separately to identically prepared mixtures 
of azlactone  (0.10 mmol), 1-naphthylmethanol (0.10 mmol), and Na2SO4. The solutions 
were transferred into NMR tubes and checked by 
1
H NMR at time intervals indicated 
below, monitoring peaks at δ 5.5 ppm (singlet, starting material) and δ 5.8 ppm (doublet, 
product). The test was conducted analogously with lower catalyst loadings of acid-
washed catalyst  (using 0.002 M and 0.001 M stock solutions, respectively). In each case, 
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enantiomeric purity of the product was determined. The data shown in on the graph in 
Figure 2 are listed in Table 1S. 
4.4.4 Optimized DKR procedure (Acid-washed catalyst) 
 
     To a mixture of a freshly prepared azlactone substrate (0.10 mmol), 1-
naphthylmethanol (0.11 mmol), and ca. 50 mg of Na2SO4, was added a solution of 
catalyst (0.005 mmol, washed w/HCl) in 1 mL of CHCl3. After 12-24 h, the mixture was 
applied directly to a silica gel column and eluted with hexane/CH2Cl2/EtOAc (10:3:3). 
Enantiomeric excess of the ester products was determined either directly by HPLC 
analysis or (for R1 = i-Pr) after LAH reduction to the alcohol. 
4.4.5 Absolute configuration of the products 
     Absolute configuration of the major enantiomer was determined in the case of esters 
with R1 =Ph, Me and i-Pr by HPLC comparison with authentic samples derived from 
commercially available amino acids. In the case of other e with R1 = Aryl, the absolute 
configuration was assigned by analogy with R1 = Ph. 
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4.4.6 Synthesis of azlactones 
General procedure     
      To a suspension of N-3, 5-dimethoxylbenzoyl amino acid (1 mmol) in 15 ml CH2Cl2, 
was added a solution of 1, 3-dicyclohexylcarbodiimide (0.206 g, 1 mmol) in 10 ml 
CH2Cl2 at 0 , then warmed up to room temperature. The mixture was continued to stir at 
room temperature for about 2h, then filtered to remove the 1, 3-dicyclohexylurea. The 
filtrate was washed with sat. NaHCO3 and brine, dried by Na2SO4 and concentrated to 
about 2 ml which was filter through Acrodisc. Then about 20 ml of hexane was added, 
kept in the freezer overnight, the mother liquid was removed and the azlactone was dried 
by vaccum. 
     All yields were unoptimized. 
 
4-(4-chlorophenyl)-2-(3,5-dimethoxyphenyl)oxazol-5(4H)-one: 79% yield of pale 
powder. 
1
HNMR (300 MHz, CDCl3): 7.40 (s, 4H), 7.23-7.22 (m, 2H), 6.71-6.70 (m, 1H), 5.50 
(s, 1H), 3.86 (s, 6H); 
13
C NMR (75 MHz, CDCl3): 175.96, 163.02, 161.31, 135.08, 
132.06, 129.44, 128.42, 127.35, 106.38, 105.96, 67.72, 55.94; IR(thin film): 2938, 2359, 
1829, 1651, 1596, 1206, 1158, 911; MS: HR-ESI calculated for C17H14ClNO4H (M+H
+
) 
m/z: 332.0684  found: m/z: 332.0686. 
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4-(2-chlorophenyl)-2-(3,5-dimethoxyphenyl)oxazol-5(4H)-one: 90% yield of pale 
powder. 
1
HNMR (300 MHz, CDCl3): 7.49-7.46 (m, 1H), 7.37-7.22 (m, 5H), 6.70-6.68 (m, 1H), 
5.88 (s, 1H), 3.85 (s, 6H); 
13
CNMR (75 MHz, CDCl3): 175.35, 163.45, 161.28, 134.35, 
131.64, 130.73, 130.61, 129.96, 127.65, 127.42, 106.46, 105.88, 67.40, 55.92; IR(thin 
film): 2937, 2359, 1831, 1648, 1594, 1205, 1158, 1039, 911; MS: HR-ESI calculated for 
C17H14ClNO4H (M+H
+
) m/z: 332.0684  found: m/z: 332.0685. 
 
2-(3,5-dimethoxyphenyl)-4-(2-methoxyphenyl)oxazol-5(4H)-one: 92% yield of pale 
powder. 
1
HNMR (300 MHz, CDCl3): 7.39-7.29 (m, 2H), 7.20-7.19 (m, 2H), 7.02-6.96 (m, 1H), 
6.90 (d, J=8.1 Hz, 1H), 6.62-6.65 (m, 1H), 5.49 (s, 1H), 3.82 (s, 6H), 3.76 (s, 3H); 
13
CNMR (75 MHz, CDCl3): 177.20, 162.56, 161.19, 157.77, 130.99, 127.97, 122.50, 
121.38, 111.79, 106.09, 105.73, 66.83, 55.90; IR(thin film): 2937, 2359, 1829, 1650, 
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1595, 1157, 1040, 931; MS: HR-ESI calculated for C18H17NO5H (M+H
+
) m/z: 328.1179, 
found: m/z: 328.1191. 
 
2-(3,5-dimethoxyphenyl)-4-(naphthalen-2-yl)oxazol-5(4H)-one: 69% yield of pale 
yellow powder. 
1
HNMR (300 MHz, CDCl3): 7.91-7.84 (m, 4H), 7.56-7.50 (m, 3H), 
7.28 (d, J=2.4 Hz, 2H), 6.72 (t, J=2.1 Hz, 1H), 5.69 (s, 1H), 3.87 (s, 6H); 
13
CNMR (75 
MHz, CDCl3): 176.33, 162.88, 161.31, 133.51, 130.93, 129.25, 128.32, 127.99, 126.82, 
126.45, 124.43, 106.36, 105.98, 66.67, 55.95; IR(thin film): 2936, 2360, 1829, 1651, 
1595, 1205, 1157, 1045, 909; MS: HR-ESI calculated for C21H17NO4H (M+H
+
) m/z: 
348.1230, found: m/z: 348.1232. 
 
2-(3,5-dimethoxyphenyl)-4-(naphthalen-1-yl)oxazol-5(4H)-one: 59% yield of pale 
powder. 
1
HNMR (300 MHz, CDCl3): 8.18 (d, J=8.4 Hz, 1H), 7.94-7.88 (m, 2H), 7.68-7.55 (m, 
2H), 7.49-7.40 (m, 2H), 7.28 (d, J=2.7 Hz, 2H), 6.72-6.70 (m, 1H), 6.28 (s, 1H), 3.86 (s, 
6H); 
13
C NMR (75 MHz, CDCl3): 176.04, 162.97, 161.30, 134.40, 131.27, 129.92, 
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129.66, 129.16, 127.62, 127.18, 126.47, 125.53, 125.16, 123.89, 106.37, 105.92, 66.29, 
55.92; IR(thin film): 2938, 2359, 1826, 1651, 1595, 1205, 1158, 1036, 912; MS: HR-ESI 
calculated for C21H17NO4H (M+H
+
) m/z: 348.1230, found: m/z: 348.1231. 
 
2-(3,5-dimethoxyphenyl)-4-isopropyloxazol-5(4H)-one: 78% yield of white powder 
recrystalized from hexane. 
1
HNMR (300 MHz, CDCl3): 7.15-7.14 (m,2H), 6.65 (s, 1H), 
4.28 (d, J=4.2 Hz, 1H), 3.84 (s, 6H), 2.41-2.35 (m, 1H), 1.14 (d, J=6.6 Hz, 3H), 1.02 (d, 
J=6.9 Hz, 3H); 
13
CNMR (75 MHz, CDCl3): 177.93, 161.80, 161.19, 127.83, 105.88, 
105.69, 71.02, 55.88, 31.49, 18.39, 17.80; IR(thin film): 2938, 2359, 1826, 1651, 1595, 
1205, 1158, 1036, 912; MS: HR-ESI calculated for C14H17NO4H (M+H
+
) m/z: 264.1230, 
found: m/z: 246.1232. 
 
2-(3,5-dimethoxyphenyl)-4-methyloxazol-5(4H)-one: 64% yield of white powder. 
1
HNMR (300 MHz, CDCl3): δ 7.12 (d, J=2.1 Hz, 2H), 6.65-6.64 (m, 1H), 4.45 (AB,1H), 
3.83 (s, 6H), 1.59 (d, J=7.5 Hz, 3H); 
13
CNMR (75 MHz, CDCl3): 179.09, 161.71, 
161.19, 127.76, 105.99, 105.63, 61.35, 55.85, 17.10; IR(thin film): 2938, 2359, 1826, 
84 
1651, 1595, 1205, 1158, 1036, 912; MS: HR-ESI calculated for C12H13NO4H (M+H
+
) 
m/z: 236.0917, found: m/z: 236.0919. 
4.4.7 Characterization data and HPLC properties of the products 
 
benzyl 2-benzamido-2-phenylacetate: 
1
HNMR (300 MHz, CDCl3): δ 7.74-7.71 (m, 2H), 7.44-7.10 (m, 13H), 5.75 (d, J=7.2 Hz, 
1H), 5.13 (A of AB, JAB=12.6 Hz, 1H), 5.09 (B of AB, JAB=12.6 Hz, 1H); 
13
CNMR (75 
MHz, CDCl3): δ 171.13, 166.79, 136.75, 135.34, 133.88, 132.10, 129.23, 128.84, 128.77, 
128.61, 128.18, 127.62, 127.41, 67.77, 57.17; IR(thin film): 3319, 3062, 1742, 1644, 
1520, 1485, 1327, 1171, 696; MS: HR-ESI calculated for C22H19NO3H (M+H
+
) m/z: 
346.1445,  found: m/z: 346.1438. HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 
mL/min): (R)-enantiomer: 27.1 min; (S)-enantiomer: 33.8 min. 
 
benzyl 2-(4-chlorobenzamido)-2-phenylacetate:  
1
HNMR (300 MHz, CDCl3): -7.74 (m, 2H), 7.42-7.28 (m, 9H), 7.23-7.19 (m, 2H), 
7.13 (d, J = 6.6 Hz, 1H), 5.80 (d,  J = 6.9 Hz, 1H), 5.19 (A of AB, JAB=12 Hz, 1H), 5.17 
(B of AB, JAB=12 Hz, 1H); 
13
CNMR (75 MHz, CDCl3): 171.02, 165.71, 138.40, 136.53, 
135.23, 132.23, 129.26, 129.11, 128.90, 128.82, 128.77, 128.64, 128.17, 127.58, 100.08, 
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67.85, 67.20; IR(thin film): 3323, 3033, 2922, 1739, 1639, 1525, 1484, 1172, 696; MS: 
HR-ESI calculated for C22H18ClNO3H (M+H
+
) m/z: 380.1048  found: m/z: 380.1035. 
HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (R)-enantiomer: 8.8 min; 
(S)-enantiomer: 19.8 min. 
 
benzyl 2-(4-methoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.79 (d, J = 8.7 Hz, 2H), 7.43-7.29 (m, 8H), 7.22-7.19 (m, 
2H), 7.23-7.19 (m, 2H), 6.92 (d,  J = 8.7 Hz, 2H), 7.13 (d, J = 6.6 Hz, 1H), 5.82 (d,  J = 
6.9 Hz, 1H), 5.22 (A of AB, JAB=12 Hz, 1H), 5.18 (B of AB, JAB=12 Hz, 1H), 3.84 (s, 
3H); 
13
C NMR (75 MHz, CDCl3): δ 171.25, 166.29, 162.72, 136.90, 135.36, 129.24, 
129.18, 128.74, 128.57, 128.14, 127.59, 126.14, 114.02, 67.71, 57.11, 55.64; IR (KBr, 
cm
-1
) 3317, 2922, 1741, 1641, 1606, 1496, 1254, 1175, 697; MS: HR-ESI calculated for 
C23H21NO4H (M+H
+
) m/z: 376.1543, found m/z: 376.1536; HPLC (CHIRALCEL OD-H, 
IPA/hexane=3/10, 1.0 mL/min): (R)-enantiomer: 11.9 min; (S)-enantiomer: 24.6 min. 
 
benzyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.43-7.26 (m, 8H), 7.23-7.16 (m,2H), 6.94-6.93 (m, 2H), 
6.59-6.57 (m, 1H), 5.80 (d,  J = 6.9 Hz, 1H), 5.22 (A of AB, JAB=12 Hz, 1H), 5.18 (B of 
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AB, JAB=12 Hz, 1H),  3.80 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 170.99, 166.65, 
161.13, 136.63, 136.05,135.32, 129.21, 128.82, 128.76, 128.59,128.16, 127.61, 105.32, 
104.23, 67.75, 57.24, 55.81; IR (KBr, cm
-1
) 3315, 2923, 1743, 1648, 1594, 1521, 
1205,1157,697; MS: HR-ESI calculated for C24H23NO5H (M+H
+
) m/z: 406.1649, found 
m/z: 406.1643; HPLC (CHIRALCEL OD-H, IPA/hexane= 3/10, 1.0 mL/min): (S)-
enantiomer: 18.9 min; (R)-enantiomer: 28.0 min. 
 
methyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.45-7.34 (m, 5H), 7.12 (d, J = 6.6 Hz, 1H), 6.94-6.93 (m, 
2H), 6.59-6.57 (m, 1H), 5.74 (d,  J = 6.9 Hz, 1H), 3.81 (s, 6H), 3.76 (s, 3H); 
13
C NMR 
(75 MHz, CDCl3): δ 171.82, 166.82, 161.33,136.90, 136.22, 129.46, 129.06, 127.76, 
105.52, 104.37, 57.31, 56.02, 53.33; IR (KBr, cm
-1
) 3315, 2923, 1743, 1648, 1594, 1521, 
1205, 1157, 697; MS: HR-ESI calculated for C18H19NO5H (M+H
+
) m/z: 330.1336, found 
m/z: 330.1327; HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-
enantiomer: 15.6 min; (R)-enantiomer: 18.1 min. 
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isopropyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.44-7.25 (m, 5H), 7.14 (d, J = 6.9 Hz, 1H), 6.94-6.93 (m, 
2H), 6.59-6.57 (m, 1H), 5.69 (d, J = 6.6 Hz, 1H), 5.12-5.04 (m, 1H), 3.81 (s, 6H), 1.29 (d, 
J = 6.3 Hz, 3H), 1.12 (d, J= 6.0 Hz, 3H); 
13
C NMR (75 MHz, CDCl3): δ 170.63, 166.55, 
161.12, 137.03, 136.21, 129.11, 128.63, 127.43, 105.29, 104.15, 70.09, 57.20, 55.82, 
21.94, 21.57; IR (KBr, cm
-1
) 3319, 2922, 1737, 1651, 1594, 1520, 1456, 1354, 1206, 
1157, 1105, 1064, 698; MS: HR-ESI calculated for C20H23NO5H (M+H
+
) m/z: 358.1649, 
found m/z: 358.1636; HPLC (CHIRALCEL AS-H, IPA/hexane=2/10, 1.0 mL/min): (S)-
enantiomer: 11.3min; (R)-enantiomer: 14.2 min. 
 
allyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.46-7.31 (m, 5H), 7.13 (d, J = 6.9 Hz, 1H), 6.94-6.93 (m, 
2H), 6.59-6.57 (m, 1H), 5.91-5.79 (m, 1H), 5.76 (d, J = 6.9 Hz, 1H), 5.24-20 (m, 1H), 
5.18-5.17 (m, 1H) 4.68-4.64 (m, 2H), 3.81 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 170.83, 
166.62, 161.13, 136.69, 136.05, 131.47, 129.24, 128.85, 118.94, 105.31, 104.19, 66.54, 
57.19, 55.81; IR (KBr, cm
-1
) 3313, 2921, 1742, 1646, 1594, 1521, 1455, 1352, 1205, 
1157, 1054, 699; MS: HR-ESI calculated for C20H21NO5H (M+H
+
) m/z: 356.1492, found 
m/z: 356.1483; HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (R)-
enantiomer: 31.8 min; (S)-enantiomer: 58.8 min. 
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4-bromobenzyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.43-7.33 (m, 7H), 7.11-7.04 (m, 3H), 6.93-6.92 (m, 2H), 
6.59-6.58 (m, 1H), 5.76 (d, J = 6.9 Hz, 1H), 5.13 (s, 2H), 3.80 (s, 6H); 
13
C NMR (75 
MHz, CDCl3): δ 170.88, 166.70, 161.14, 136.40, 135.94, 134.36, 131.91, 129.76, 129.29, 
128.96, 127.61, 122.64, 105.32,104.20,  66.86, 57.27, 55.82; IR (KBr, cm
-1
) 3315, 2922, 
1744, 1652, 1594, 1519, 1455, 1352, 1205, 1157, 1069, 698; MS: HR-ESI calculated for 
C24H22BrNO5H (M+H
+
) m/z: 484.0754, found m/z: 484.0735; HPLC (CHIRALCEL 
OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 24.4 min; (R)-enantiomer: 41.7 
min. 
 
 
4-methoxybenzyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.40-7.32 (m, 4H), 7.19-7.12 (m, 3H), 6.85-6.82 (m, 2H), 
6.59-6.57 (m, 1H), 5.17 (A of AB, JAB=12 Hz, 1H), 5.10 (B of AB, JAB=12 Hz, 1H), 3.81 
(s, 6H), 3.79 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 171.23, 166.59, 161.13, 159.97, 
136.71, 136.09, 130.13, 129.17, 128.76, 127.56, 114.14, 105.30,104.20,  67.71, 57.19, 
55.80, 55.48; IR (KBr, cm
-1
) 3316, 2918, 2849, 1739, 1653, 1593, 1514, 1456, 1352, 
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1248, 1205, 1157, 1064, 1032, 822, 699; MS: HR-ESI calculated for C25H25NO6H 
(M+H
+
) m/z: 436.1755, found m/z: 436.1769; HPLC (CHIRALCEL OD-H, 
IPA/hexane=2/10, 1.0 mL/min): (S)-enantiomer: 27.4 min; (R)-enantiomer: 36.4 min. 
 
perfluorobenzyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.38-7.33 (m, 5H), 6.97 (d, J = 6.6 Hz, 1H), 6.92-6.91 (m, 
2H), 6.59-6.58 (m, 1H), 5.73 (d, J = 6.9 Hz, 1H), 5.28 (s, 2H), 3.81 (s, 6H); 
13
C NMR 
(75 MHz, CDCl3): δ 170.50, 166.75, 161.15, 135.84, 135.80, 129.29, 129.08, 127.48, 
105.31, 104.22, 57.16, 55.81, 54.72; IR (KBr, cm
-1
) 3316, 2921, 1751, 1657, 1594, 1523, 
1508, 1456, 1353, 1206, 1157, 1061, 941, 698; MS: HR-ESI calculated for 
C24H18F5NO5H (M+H
+
) m/z: 496.1178, found m/z: 496.1172; HPLC (CHIRALCEL AD-
H, IPA/hexan=2/10, 1.0 mL/min): (S)-enantiomer: 15.3 min; (R)-enantiomer: 31.3 min. 
 
naphthalen-2-ylmethyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.83-7.72 (m, 3H), 7.62 (s, 1H), 7.51-7.42 (m, 4H), 7.36-
7.34 (m, 3H), 7.31-7.28 (m, 1H), 7.15 (d, J = 6.6 Hz, 1H), 6.95-6.94 (m, 2H), 6.59-6.58 
(m, 1H), 5.83 (d, J = 6.9 Hz, 1H), 5.34 (s, 2H), 3.80 (s, 6H); 
13
C NMR (75 MHz, CDCl3): 
δ 171.00, 166.66, 161.14, 136.65, 136.05, 133.33, 133.30, 132.77, 129.26, 128.88, 128.59, 
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128.21, 127.90, 127.64, 127.16, 126.54, 125.54, 105.30, 104.23,  67.80, 57.30, 55.82; IR 
(KBr, cm
-1
) 3318, 2920, 1741, 1652, 1594, 1510, 1455, 1353, 1205, 1156, 1064, 698; MS: 
HR-ESI calculated for C28H25NO5H (M+H
+
) m/z: 456.1805, found m/z: 456.1816; 
HPLC (CHIRALCEL OD-H, IPA/hexane=4/10, 1.0 mL/min): (S)-enantiomer: 30.1 min; 
(R)-enantiomer: 42.3 min. 
 
naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.87-7.82 (m, 2H), 7.77-7.74 (m, 1H), 7.51-7.37 (m, 6H), 
7.32-7.28 (m, 3H), 7.2 (d, J = 6.9 Hz, 1H), 6.95-6.93 (m, 2H), 6.59-6.58 (m, 1H), 5.79 (d, 
J = 6.9 Hz, 1H), 5.64 (s, 2H), 3.78 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 171.04, 166.68, 
161.13, 136.52, 136.05, 133.88, 131.67, 130.72, 129.76, 129.18128.85, 128.80, 127.68, 
127.58, 126.82, 126.19, 125.36,123.63, 105.33, 104.24,  66.46, 57.34, 55.82; IR (KBr, 
cm
-1
) 3327, 2920, 1740, 1651, 1594, 1512, 1456, 1353, 1263, 1205, 1156, 1063, 1049, 
792, 776; MS: HR-ESI calculated for C28H25NO5H (M+H
+
) m/z: 456.1805, found m/z: 
456.1814; HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 
24.8 min; (R)-enantiomer: 46.1 min. 
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pyren-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 8.21-8.19 (m, 2H), 8.11-8.00 (m, 6H), 7.93 (d, J = 7.8 Hz, 
1H), 7.39-7.36 (m, 3H), 7.26-7.24 (m, 2H), 7.13 (d, J = 6.9 Hz, 1H), 6.92-6.91 (m, 2H), 
6.57-6.55 (m, 1H), 5.89 (s, 2H), 5.81 (d, J = 6.9 Hz, 1H), 3.76 (s, 6H); 
13
C NMR (75 
MHz,CDCl3): δ 171.06, 166.66, 161.10, 136.49, 136.04, 132. 11, 131.38, 130.86, 129.73, 
129.17, 128.78, 128.45,128.17, 128.02, 127.84, 127.54, 126.32, 125.77, 125.74,125.02, 
125.76, 124.70, 122.90, 195.29, 104.20, 66.68, 57.39, 55.79; IR (KBr, cm
-1
) 3329, 2922, 
1734, 1639, 1593, 1520, 1455, 1352, 1260, 1205, 1156, 1064, 844, 750; MS: HR-ESI 
calculated for C34H27NO5Na (M+Na
+
) m/z: 552.1781, found m/z: 552.1805; HPLC 
(CHIRALCEL OD-H, IPA/hexane=4/10, 1.0 mL/min): (S)-enantiomer: 22.8 min; (R)-
enantiomer: 40.7 min. 
 
naphthalen-1-ylmethyl 2-(4-chlorophenyl)-2-(3,5-dimethoxybenzamido)acetate 
1
HNMR (300 MHz, CDCl3): δ 7.87-7.83 (m, 2H), 7.69 (d, J = 8.1 Hz, 1H), 7.52-7.47 (m, 
4H), 7.43-7.37 (m, 5H), 7.28-7.18 (m, 5H), 6.91 (d, J = 2.4 Hz, 2H), 6.59-6.57 (m, 1H), 
5.72 (d, J = 6.6 Hz, 1H), 5.65 (A of AB, JAB=12 Hz, 1H), 5.62 (B of AB, JAB=12 Hz, 1H)),  
3.79 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 170.64, 166.56, 161.16, 135.80, 135.17, 
134.67, 133.89, 131.63, 130.43, 129.95,129.24, 128.89, 128.82, 127.99, 126.85, 126.26, 
125.30,123.49, 105.29, 104.29,  66.77, 56.67, 55.81; IR (KBr, cm
-1
) 3299, 2923, 1740, 
1644, 1594, 1513, 1492, 1352, 1205, 1157, 1091, 1064, 794, 775; MS: HR-ESI 
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calculated for C28H24ClNO 5H (M+H
+
) m/z: 490.1416, found m/z: 490.1410; HPLC 
(CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 35.6 min; (R)-
enantiomer: 47.9 min. 
 
naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-(4-methoxyphenyl)acetate 
1
HNMR (300 MHz, CDCl3): δ 7.86-7.82 (m, 2H), 7.77-7.74 (m, 1H), 7.51-7.38 (m, 4H), 
7.30-7.26 (m, 2H), 7.07 (d, J = 6.6 Hz, 1H), 6.91 (d, J = 2.1 Hz, 2H), 6.82-6.77 (m, 2H), 
6.57 (t, J = 2.1Hz, 1H), 5.70 (d, J = 6.9 Hz, 1H), 5.63 (s, 2H), 3.79 (s, 6H), 3.77 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 192.25, 171.22, 166.62, 161.11, 159.97, 136.11, 133.87, 
131.68, 130.77, 129.73, 128.79, 128.59, 127.71, 126.77, 126.15, 125.35, 123.68,114.54, 
105.28, 104.20,  66.38, 56.77, 55.51; IR (KBr, cm
-1
) 3316, 2924, 1741, 1653, 1594, 1512, 
1458, 1353, 1249, 1205, 1177, 1157, 1063, 797; MS: HR-ESI calculated for C29H27NO 
6H (M+H
+
) m/z: 486.1911, found m/z: 486.1934; HPLC (CHIRALCEL OD-H, 
IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 35.0 min; (R)-enantiomer: 49.9 min. 
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naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-(3-methoxyphenyl)acetate 
1
HNMR (300 MHz, CDCl3): δ 7.87-7.82 (m, 2H), 7.77-7.75 (m, 1H), 7.51-7.38 (m, 4H), 
7.26-7.18 (m, 1H), 7.11 (d, J = 6.6 Hz, 1H), 6.97-6.81 (m, 5H), 6.59-6.58 (m, 1H), 5.75 
(d, J = 7.2 Hz, 1H), 5.64 (s, 2H), 3.80 (s, 6H), 3.66 (s, 3H); 
13
C NMR (75 MHz, CDCl3): 
δ 170.90, 166.66, 161.13, 160.17, 137.88, 136.04, 133.88, 131.68, 130.72, 130.20, 129.78, 
128.83, 127.78, 126.84, 126.19, 125.35, 123.64, 119.69, 114.63, 112.96, 105.31, 104.24,  
66.49, 57.26, 55.40; IR (KBr, cm
-1
) 3313, 2923, 1741, 1651, 1595, 1513, 1456, 1353, 
1263, 1205, 1156, 1063, 1049, 792, 776; MS: HR-ESI calculated for C29H27NO 6H 
(M+H
+
) m/z: 486.1911, found m/z: 486.1910; HPLC (CHIRALCEL OD-H, 
IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 26.5 min; (R)-enantiomer: 47.0 min. 
 
naphthalen-1-ylmethyl 2-(2-chlorophenyl)-2-(3,5-dimethoxybenzamido)acetate 
1
HNMR (300 MHz, CDCl3): δ 7.85-7.76 (m, 3H), 7.49-7.36 (m, 5H), 7.32-7.13 (m, 4H), 
6.92-6.91 (m, 2H), 6.58-6.56 (m, 1H), 6.11 (d, J = 7.2 Hz, 1H), 5.66 (s, 2H), 3.78 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 170.33, 166.59, 161.11, 135.94, 134.83, 133.83, 133.78, 
131.63, 130.70, 130.67, 130.36, 129.92, 129.69, 128.80, 127.63, 127.44, 126.72, 126.11, 
125.30, 123.57, 105.32, 104.27,  66.64, 57.79, 55.67; IR (KBr, cm
-1
) 3315, 2924, 1743, 
1651, 1594, 1512, 1456, 1352, 1205, 1157, 1063, 797, 754, 735; MS: HR-ESI calculated 
for  C28H24ClNO 5H (M+H
+
) m/z: 490.1416, found m/z: 490.1410; HPLC (CHIRALCEL 
OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 32.6 min; (R)-enantiomer: 79.1 
min. 
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naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-(2-methoxyphenyl)acetate 
1
HNMR (300 MHz, CDCl3): δ 7.82 (t, J = 8.1 Hz, 2H), 7.73 (d, J = 8.1 Hz, 1H), 7.49-
7.32 (m, 5H), 7.27-7.20 (m, 2H), 6.95-6.88 (m, 3H), 6.65 (d, J = 8.4 Hz, 1H),  6.56-6.55 
(m, 1H), 5.96 (d, J = 8.1 Hz, 1H), 5.67 (A of AB, JAB=12 Hz, 1H), 5.57 (B of AB, JAB=12 
Hz, 1H), 3.78 (s, 6H), 3.30 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 171.04,166.73, 161.03, 
157,10, 136.61, 133.84, 131.76, 131.34, 131.12, 129.96, 129.40, 128.68, 127.72, 126.66, 
126.03, 125.50,125.36, 123.81, 121.18, 111.03, 105.34, 103.94, 66.04, 55.76, 55.13, 
54.49; IR (KBr, cm
-1
) 3353, 2922, 1743, 1659, 1594, 1512, 1495, 1461, 1351, 1252, 
1205, 1147, 1063, 755; MS: HR-ESI calculated for C29H27NO 6H (M+H
+
) m/z: 486.1911, 
found m/z: 486.1895; HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-
enantiomer: 26.9 min; (R)-enantiomer: 38.8 min. 
 
naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-(naphthalen-1-yl)acetate 
1
HNMR (300 MHz, CDCl3): δ 8.16-8.13 (m, 1H), 7.86-7.78 (m, 3H), 7.67 (d, J = 8.1 Hz, 
1H), 7.49-7.24 (m, 8H), 7.05 (d, J = 7.5 Hz, 2H), 6.90-6.89 (m, 2H), 6.56-6.52 (m, 2H), 
5.66 (s, 2H), 3.76 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 171.53,166.92, 161.09, 135.96, 
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134.31, 133.79, 132.41, 131.60, 131.30, 130.72, 129.71, 129.65, 129.10, 128.72, 127.75, 
127.25, 126.67, 126.35, 126.07, 125.37, 125.27, 123.58, 123.44, 105.33, 104.27, 66.41, 
55.80, 54.50; IR (KBr, cm
-1
) 3312, 2922, 1740, 1653, 1594, 1511, 1457, 1349, 1205, 
1194, 1156, 1063, 792, 776; MS: HR-ESI calculated for C32H27NO 5H (M+H
+
) m/z: 
506.1962, found m/z: 506.1941; HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 
mL/min): (S)-enantiomer: 22.9 min; (R)-enantiomer: 66.6 min. 
 
naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-2-(naphthalen-2-yl)acetate 
1
HNMR (300 MHz, CDCl3): δ 7.82-7.74 (m, 5H), 7.69  (d, J = 8.4 Hz, 1H), 7.51-7.34 (m, 
6H), 7.27-6.95 (m, 2H), 6.95-6.94 (m, 1H), 6.59-6.58 (m, 1H), 5.96 (d, J = 6.6 Hz, 1H), 
5.64 (s, 2H), 3.79 (s, 6H); 
13
C NMR (75 MHz,CDCl3): δ 170.05, 166.70, 161.14, 136.04, 
133.88, 133.84, 133.47, 133.44, 131.65, 130.64, 129.81, 129.10,128.77, 128.33, 127.87, 
126.93, 126.73, 126.68, 126.63, 126.14, 125.30, 124.98, 123.55, 105.33, 104.29, 66.61, 
57.43, 55.80;  IR (KBr, cm
-1
) 3313, 2923, 1741, 1654, 1595, 1511, 1458, 1351, 1205, 
1157, 1064, 793,776; MS: HR-ESI calculated for C32H27NO 5H (M+H
+
) m/z: 506.1962, 
found m/z: 506.1939; HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 mL/min): (S)-
enantiomer: 27.1 min; (R)-enantiomer: 50.7 min. 
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naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)-3-methylbutanoate 
1
HNMR (300 MHz, CDCl3): δ 8.03-7.99 (m, 1H), 7.91-7.86 (m, 2H), 7.58-7.43 (m, 4H), 
6.90 (d, J = 2.1 Hz, 2H), 6.60-6.58 (m, 2H), 5.71 (A of AB, JAB=12 Hz, 1H), 5.61 (B of 
AB, JAB=12 Hz, 1H), 4.82 (dd,   J1 = 8.7 Hz,  J2 = 4.5 Hz, 1H), 3.80 (s, 6H), 2.32-2.17 (m, 
1H), 0.94 (d, J = 6.6 Hz, 3H),  0.87 (d,  J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  δ 
172.18, 167.40, 161.13, 136.64, 133.95, 131.80, 130.99, 129.84, 128.99, 128.11, 126.94, 
126.27, 125.45, 123.65, 105.23, 103.96, 65.73, 57.76, 55.79, 31.84, 19.27, 17.91; IR 
(KBr, cm
-1
) 3328, 2961, 2924, 1736, 1654, 1594, 1525, 1458, 1355, 1205, 1156, 1064, 
794, 777; MS: HR-ESI calculated for C25H27NO 5H (M+H
+
) m/z:  422.1962, found m/z:  
422.1960; HPLC (for alcohol obtained by LAH reduction) (CHIRALCEL AS-H, 
IPA/hexane=1/10, 1.0 mL/min): (S)-enantiomer: 13.2 min; (R)-enantiomer: 26.7 min. 
 
naphthalen-1-ylmethyl 2-(3,5-dimethoxybenzamido)propanoate 
1
HNMR (300 MHz, CDCl3): δ 8.01-7.98 (m, 1H), 7.91-7.86 (m, 2H), 7.57-7.43 (m, 4H), 
6.90 (d, J = 2.4 Hz, 2H), 6.73 (d,  J = 6.9 Hz, 1H), 6.58-6.57 (m, 1H), 5.70 (A of AB, 
JAB=15 Hz, 1H), 5.64 (B of AB, JAB=15 Hz, 1H), 4.87-4.77 (m, 1H), 3.80 (s, 6H), 1.48 (d, 
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J = 7.2 Hz, 3H); 
13
C NMR (75 MHz, CDCl3): δ 173.20, 166.92, 161.11, 136.36, 133.98, 
131.79, 130.98, 129.84, 129.00, 127.91, 126.97, 126.28, 125.45, 123.62, 105.16, 104.17, 
66.00, 55.79, 48.99, 18.76; IR (KBr, cm
-1
) 3319, 2925, 1741, 1645, 1594, 1532, 1456, 
1354, 1205, 1156, 1063, 776; MS: HR-ESI calculated for C23H37NO 5H (M+H
+
) m/z:  
394.1649, found m/z: 394.1640;HPLC (CHIRALCEL OD-H, IPA/hexane=3/10, 1.0 
mL/min): (S)-enantiomer: 33.4 min; (R)-enantiomer: 38.6 min. 
 
isobutyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.45-7.42 (m, 2H), 7.39-7.29 (m, 3H), 7.19 (d, J = 6.6 Hz, 
1H), 6.95-6.94 (m, 2H), 6.59-6.57 (m, 1H), 5.74 (d, J = 6.9 Hz, 1H), 3.96-3.93 (m, 2H), 
3.81 (s, 6H), 1.98-1.80 (m, 1H), 0.82 (dd,  J1 = 6.6 Hz,  J2 = 1.5 Hz, 6H); 
13
C NMR (75 
MHz, CDCl3): δ 171.20, 166.59, 161.13, 137.01, 136.13, 129.14, 128.72, 127.47, 105.30, 
104.18, 72.12, 57.20, 55.80, 27.88, 19.04; IR (KBr, cm
-1
) 3316, 2961, 1741, 1651, 1595, 
1522, 1456, 1353, 1206, 1157, 1065, 699; MS: HR-ESI calculated for  C21H25NO 5H 
(M+H
+
) m/z:   372.1805, found m/z:  372.1808; HPLC (CHIRALCEL OD-H, 
IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 21.3 min; (R)-enantiomer: 34.6 min. 
 
98 
neopentyl 2-(3,5-dimethoxybenzamido)-2-phenylacetate 
1
HNMR (300 MHz, CDCl3): δ 7.46-7.43 (m, 2H), 7.39-7.31 (m, 3H), 7.21 (d, J = 6.9 Hz, 
1H), 6.96-6.95 (m, 2H), 6.59-6.58 (m, 1H), 5.75 (d, J = 6.9 Hz, 1H), 3.93-3.78 (m, 8H), 
0.82 (s, 6H); 
13
C NMR (75 MHz, CDCl3): δ 171.20, 166.58, 161.14, 137.09, 136.15, 
129.12, 128.71, 127.43, 105.30, 104.18, 75.27, 57.25, 55.82, 31.72, 26.41; IR (KBr, cm
-1
) 
3318, 2958, 1741, 1648, 1594, 1522, 1205, 1157, 698; MS: HR-ESI calculated for 
C22H27NO 5H (M+H
+
) m/z: 386.1962, found m/z: 386.1968; HPLC (CHIRALCEL OD-H, 
IPA/hexane=3/10, 1.0 mL/min): (S)-enantiomer: 15.6 min; (R)-enantiomer: 39.9 min. 
 
1
HNMR (300 MHz, CDCl3): δ 7.80 (d, J =7.2 Hz, 2H), 7.01 (d, J = 6.9 Hz, 1H), 5.21 (A 
of AB, JAB=12 Hz, 1H), 5.17 (B of AB, JAB=12 Hz, 1H), 4.88-4.79 (m, 1H), 1.51(d, J 
=7.2 Hz, 3H); 
13
C NMR (75 MHz, CDCl3): δ 173.29, 167.18, 
135.59, 134.14, 131.91, 128.86, 128.75, 128.67, 128.34, 127.33, 67.43, 48.86, 18.66; IR 
(KBr, cm
-1
) 3331, 1738, 1650, 1520, 909, 732; MS: HR-ESI calculated for C17H16NO 3H 
(M+H
+
) m/z: 284.1281, found m/z: 284.1279; HPLC (CHIRALCEL OD-H, 
IPA/hexane=1/10, 1.0 mL/min): (R)-enantiomer: 15.4 min; (S)-enantiomer: 17.7 min. 
 
99 
IR (KBr, cm
-1
) 3367, 1736, 1655, 1594, 1206, 1157; MS: HR-ESI calculated for 
C26H25NO5H (M+H
+
) m/z: 432.1806, found m/z: 432.1807;  
 
IR (KBr, cm
-1
) 3330, 1740, 1655, 1595, 1517, 1355, 1206, 1157, 1063; MS: HR-ESI 
calculated for C29H27NO5H (M+H
+
) m/z: 470.1962, found m/z: 470.1961;  
4.4.8 General procedure to prepare oxazinones 
 
     The mixture of N-protected β-amino acid (329mg, 1mmol) and DCC (206mg, 1mmol) 
in 10ml CH2Cl2 was stirred at room temperature for 3h, filtered to remove the precipitate. 
The filtrate was concentrate and purified by column chromatography (Silica gel, 
EtOAc:Hexane=1:5) to give 150mg white powder as the product. 
1
HNMR (300 MHz, CDCl3): δ 7.34-7.24 (m, 5H), 7.20-7.19 (m, 2H), 6.56 (t, J = 2.29 Hz, 
1H), 4.99 (X of ABX, 1H), 3.77 (s, 6H), 2.99 (A of ABX, JAB=15Hz, JAX=27Hz, 1H), 
2.97 (B of ABX, JAB=18Hz, JBX=30Hz, 1H);; 
13
C NMR (75 MHz, CDCl3): 166.08, 
161.39, 154.08, 141.02, 132.76, 129.54, 128.53, 126.84, 106.21, 105.51, 57.19, 56.23, 
36.79; IR (KBr, cm
-1
) 1788, 1670, 1596, 1454, 1205, 1156, 1062, 1030; MS: HR-ESI 
calculated for C18H17NO4H (M+H
+
) m/z: 312.1230, found m/z: 312.1233;  
100 
4.4.9 General procedure for kinetic resolution of oxazinones 
 
     The mixture of oxazinone (25mg, 0.1mmol), benzyl alcohol (5.2 µl, 0.05mmol) and 
0.005mmol catalyst in 1ml CDCl3 was stirred at room temperature. The reaction was 
monitored by 
1
HNMR until the conversion reached 45-50%. The mixture was purified by 
column chromatography (Silica gel, EtOAc:Hexane=1:5) to give the unreacted oxazinone 
and (EtOAc:CH2Cl2:Hexane=3: 3:10) to give the product. 
1
HNMR (300 MHz, CDCl3): δ 7.72-7.69 (m, 2H), 7.46-7.12 (m, 14H), 5.62-5.55(m, 1H), 
5.02 (A of AB, JAB=12 Hz, 1H), 4.99 (B of AB, JAB=12 Hz, 1H), 2.97 (A of ABX, 
JAB=15Hz, JAX=27Hz, 1H), 2.95 (B of ABX, JAB=15Hz, JBX=30Hz, 1H); 
13
C NMR (75 
MHz, CDCl3) :δ 171.58, 166.68, 140.57, 135.49, 134.35, 131.85, 128.99, 128.82, 128.61, 
128.50, 127.88, 127.24, 126.45, 66.98, 50.03, 40.17; IR (KBr, cm
-1
) 3311, 1733, 1637, 
1537; MS: HR-ESI calculated for C23H21NO3H (M+H
+
) m/z: 360.1594, found m/z: 
360.1600; HPLC (CHIRALCEL OD-H, IPA/hexane=2/10, 1.0 mL/min): (R)-enantiomer: 
11.6 min; (S)-enantiomer: 18.5 min. 
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